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DNA damage and aberrant DNA damage response (DDR) are significant features of genomic 
instability that are implicated in the pathogenesis of myelodysplastic syndromes (MDS) and 
acute myeloid leukemia (AML).  DEAD-box helicase 41 (DDX41) is a member of helicase 
superfamily 2.  Both germline and somatic mutations of DDX41 have been associated with 
MDS and AML, and missense mutant R525H is the most frequent mutation (67%) found in 
MDS and AML patients.  However, the molecular pathogenesis of DDX41 mutations, such as 
R525H, remains unknown.  Here, I found that DDX41 protein could efficiently unwind 
RNA:DNA hybrid in vitro. This prompted us to investigate the potential role of DDX41 in DDR 
concerning R-loops, one of the significant sources of genome instability.  Examining DDX41 
knockout (KO) cells (HeLa and HT1080) and DDX41 KO cells reconstituted with DDX41-
R525H gene, I found that these cells had prolonged and increased DNA double-strand breaks 
(DSB) induced by ionizing radiation (IR) or bleomycin, a radiomimetic agent, compared to wildtype (WT) 
and DDX41 KO cells reconstituted with DDX41-WT gene, suggesting that DDX41 is crucial 
for DDR.  Using the R-loop specific antibody S9.6, dot blot assays showed increased R-loops 
in DDX41-KO and R525H-expressing cells, deciphering that DDX41 functions as an R-loop 
resolvase.  Furthermore, biochemical assays demonstrated R525H stimulates R-loops 
formation.  Lastly, I found that DDX41 colocalized with the DSB marker γH2AX, R-loop marker 
S9.6, and transcription machinery marker RNA polymerase II, indicating that DDX41 interacts 
with proteins during transcription and DNA repair.  In conclusion, our results imply that DDX41 
is required for DDR as an R-loop resolvase upon DNA damage, and lack of or impaired DDX41 
results in altered DDR response and pathogenic R-loop accumulation, which ultimately leads to 
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Helicases are the ubiquitous enzymes that transduce the chemical energy generated by 
hydrolysis of nucleoside triphosphate (NTP) into an oligonucleotide strand separation and 
displacement activity (Caruthers and McKay, 2002).  Depending on substrates, helicases can 
be classified as DNA or RNA helicases, and based on polarity, are classified as 5′→3′ or 3′→5′ 
helicases (Patel and Picha, 2000).  Helicases are engaged in amost all aspects of nucleic acid 

























Figure 1. Structures of helicase superfamilies.  An illustration of the core helicase domain.  
A blue cylinder represents the N-terminal RecA domain (RecA1), and the C-terminal RecA 
domain (RecA2) is presented as a red cylinder.  Conserved amino acid motifs are coloured 
depending on the helicase function.  Motifs in yellow are implicated in NTP binding/hydrolysis, 
motifs in green are correlated with translocation, and motifs in blue interact with the nucleic 
acid.  Distinct motifs from all the illustrated suferfamilies are highlighted with a red oval.  Motif 
I (Walker A), motif II (Walker B), and arginine finger (R) are conserved throughout all helicase 




chromosome segregation, and telomere maintenance (Bernstein et al., 2010; Brosh Jr and Bohr, 
2007; Dillingham, 2011; Jankowsky, 2011).  Helicases have been classified into six major groups, 
i.e., superfamily 1 (SF1)-SF6, based upon conserved amino acid sequence motifs (Singleton et 
al., 2007) (Figure 1).  Among them, only the SF1 and SF2 comprise nine short conserved amino 
acid sequences, named Q, I, Ia, Ib II, III, IV, V, and VI, respectively, and SF2 is the largest group 
among these six superfamilies (Byrd and Raney, 2012; Gorbalenya and Koonin, 1993).  These 
motifs are generally grouped in a section of 200–700 amino acids known as the helicase core 
domain.  The helicase family is also called the DEAD-box (or DEAH or DEXH) protein family, 
because of the sequence of motif II (Asp-Glu-Ala-Asp, DEAD) (Lohman et al., 2008).  
Furthermore, X-ray crystallographic studies demonstrate that the conserved helicase motifs are 
linked with the tertiary structure of helicase proteins, suggesting that they form a significant 
functional domain, coordinating ATP binding and hydrolysis to nucleic acids unwinding 
(Lohman et al., 2008; Singleton et al., 2007). 
 
1.2 DEAD-box helicases 
The DEAD-box helicase is the largest subfamily under superfamily 2 RNA helicases.  The 
DEAD motif, together with a motif I, Q motif, and motif VI, is required for ATP binding and 
hydrolysis (Pause et al., 1994; Pause and Sonenberg, 1992).  Moreover, the DEAD motif, along 
with motif I, is important for magnesium binding.  Motifs Ia and Ib, IV, and V are involved in 
intramolecular arrangement and RNA interaction, necessary for remodelling activity of the 
RNA helicase.  Furthermore, motif III is essential for coupling of ATP hydrolysis to remodeling 







Figure 2. Motifs and their potential functions in DEAD-box RNA helicases.  Taken from 
(Parsyan et al., 2011). 
 
Several members of the DEAD-box helicases have drawn the high interest of 
researchers, as each of the individual enzymes from these subfamilies is engaged in several 
processes of RNA metabolism.  For example, Ded1 and p72 engage in transcription and pre-
mRNA splicing (Auboeuf et al., 2002; Liu et al., 2002), Drs1p, Dhr1p, and Dhr2p in ribosomes 
biogenesis (Venema and Tollervey, 1999), Dbp5 in nuclear export (Gatfield et al., 2001), Ded1p 
in translation initiation (Chuang et al., 1997), SKI2 and LGP2 in RNA degradation (Anderson 
and Parker, 1998; Py et al., 1996), and mHel61p in organelle gene expression (Missel et al., 
1997).  Moreover, these helicases are often linked to several diseases, such as malignancy of 
tumor cells and a few human male infertility syndromes (Fuller-Pace, 2013; Lasko, 2013).  
Further, DEAD-box helicases illustrate a large family of proteins that possess a non-
processive and local dissociation activity on dsRNA substrates (Linder, 2006).  This activity is 
primarily utilized in various RNA metabolic processes by eukaryotes.  In these processes, the 
DEAD-box helicases likely act as valuable check-point proteins in the RNA metabolism 







1.3 DDX41 helicase 
DEAD-box helicase 41 (DDX41) is a member of the SF2 family (Figure 3).  DDX41 is 
expressed in a large range of species, from drosophila to plants and mammals.  DDX41 is 
composed of two domains: the N-terminal helicase core domain and the C-terminal Zinc-finger 
like domain.  A nuclear localization signal (NLS) motif is present before the helicase domain.  
These domains further comprise different functional motifs that function in binding and 
hydrolysis of ATP, recognition of nucleic acids, and unwinding DNA/RNA unwinding (Linder 
and Fuller-Pace, 2013).  Mass spectroscopy studies have revealed DDX41 is engaged in the 
second step of splicing where the 5′ and 3′ exon ligation and the release of the  
 
Figure 3. Structure and sequence of human DDX41 protein.  (A) Schematic of DDX41 
protein representing the nuclear localization sequence (NLS, in red), conserved helicase motifs 



































intronic lariat occur (Agafonov et al., 2011; Bessonov et al., 2008; Jurica et al., 2002).  A siRNA 
screening found that DDX41 functions as an intracellular DNA sensor in myeloid dendritic cells 
(Zhang et al., 2011b).  In contrast to other Pathogen recognition receptors (PRRs, a group of germ 
line-encoded receptors), DDX41 can also recognize bacterial secondary messengers such as 
cyclic-di-GMP (c-di-GMP) or cyclic-di-AMP (c-di-AMP) to activate Type I interferon immune 
response (Parvatiyar et al., 2012).  It has been shown that Bruton’s tyrosine kinase (BTK) 
phosphorylates DDX41 at Tyr414 and activates it, thereby, allowing for recognition of dsDNA 
after viral or bacterial infection (Lee et al., 2015b).  Following ligand recognition, DDX41 binds 
STING (Stimulator of Interferon Genes), and STING subsequently phosphorylates the TANK-
binding protein and interferon regulatory factor 3 (IRF3) and finally induces the production of 
type I interferon (Ishikawa and Barber, 2008; Jiang et al., 2017; Omura et al., 2016; Tanaka and 
Chen, 2012). 
Besides its role in innate immunity, both germline and acquired somatic mutations in 
DDX41 have been associated with myelodysplastic syndrome (MDS) and acute myeloid 
leukemia (AML) (Cardoso et al., 2016; Ding et al., 2012; Fenwarth et al., 2021).  The most 
frequently identified somatic mutation is c.1574G>A, p.R525H (67%), which is mainly 
confined to the highly conserved region of DDX41 ( Quesada et al., 2019; Lewinsohn et al., 
2016; Li et al., 2016b; Polprasert et al., 2015).  Moreover, mutations in DDX41 are also linked 
with acute erythroid leukemia (AEL) (Iacobucci et al., 2019).  DDX41 mutations also lead to 
failure of tumor suppressor function such as aberrant pre-mRNA splicing, RNA processing, and 
cell cycle arrest (Kadono et al., 2016; Lewinsohn et al., 2016; Polprasert et al., 2015; Qin et al., 
2021).  Another study suggested DDX41 mutants may be involved in activation of the DNA 
damage response (DDR), resulting in cell cycle arrest (Peters et al., 2017).  Although DDX41 
is well studied as an essential sensor in the field of the innate immune response, its potential role 
in DDR remains unexplored. 
 
1.4 MDS, AML and DDX41 mutations 
MDS and AML are hematologic diseases prevalent in adults 65 years of age or older (Almeida 
and Ramos, 2016; Ria et al., 2009). MDS is characterized by unsuccessful hematopoiesis and 
peripheral blood cytopenia (a disorder in which the number of blood cells are lower than 




cells. Progression of MDS increases the risk of its evolution into AML (Jiang et al., 2009).  To 
date, eleven genes, namely ANKRD26, ACD, ATG2B, CEBPA, DDX41, ETV6, GATA2, 
RUNX1, SRP72, TERC, and TERT that are indicative of germline heterozygous mutations.  
These mutations have been identified to be associated with familial MDS and AML (Duployez 
et al., 2016; Lee et al., 2015a; Tawana et al., 2018; Tawana and Fitzgibbon, 2016), of which 
DDX41 is the latest (Jahn et al., 2018; Maciejewski et al., 2017). High-throughput sequencing 
of samples from MDS and AML patients has revealed several MDS and AML-related mutations 
(Bejar et al., 2011; Haferlach et al., 2008; Mossner et al., 2016; Papaemmanuil et al., 2013); among 
those, the DDX41-R525H mutation was one of the most recurrent ones (Figure 4).  This R525H 
mutation has been revealed to have a reduction in nucleotide coordination (Li et al., 2016b), 
inhibitory effect on cell cycle progression by repressing E2F (E2F Transcription Factor) 
activity, defect in pre-rRNA processing, and diminished protein synthesis as a consequence of 
ribosomal stress (Kadono et al., 2016). 
Generally, MDS and AML progression results from elevated levels of oncogenes, 
deactivation of tumor suppressor genes, or a combination of both, which then prompts 
replication stress and genome 
 
 
Figure 4. Summary of DDX41 germline and somatic mutations reported in MDS and AML 
patients.  Nuclear localization signal (NLS, in blue), helicase motifs (yellow), and zinc finger 
(ZF, purple) domains are indicated.  The R525H mutant is highlighted. 


















































































instability (Haferlach et al., 2008; Halazonetis et al., 2008).  Several studies focus on alterations 
in DNA damage response (DDR) associated with MDS and AML in which DNA double-strand 
breaks (DSBs) are critical DNA damage and genome instability markers (Boehrer et al., 2009; 
Cavelier et al., 2009; Horibe et al., 2007; Kefala et al., 2013).  Several DNA damage response 
genes, such as ATM (Grosjean-Raillard et al., 2009), XPD and XRCC1 (Joshi et al., 2016), BRCC 
(Meyer et al., 2020), and HLTF (Takaoka et al., 2019), have been associated with MDS/AML.  
Some DEAD-box proteins, such as DDX1 (Li et al., 2008; Zhang et al., 2011a) and DDX3 (Sun 
et al., 2013; Szappanos et al., 2018), are also involved in DDR. DNA damage measured by 
γH2AX and 53BP1 (DSB markers) increases through MDS to AML; in addition, there is 
diminished DDR in MDS and AML cell lines and samples of bone marrow (Popp et al., 2017), 
suggesting that dysregulated DDR and DSB might be a potential root of MDS and AML 
pathogenesis. 
 
1.5 DNA damage and repair 
Cells are constantly subjected to DNA damage, generating thousands of DNA lesions per cell 
each day (Ciccia and Elledge, 2010).  A variety of lesions are found in DNA from three leading 
causes.  The first leading cause is environmental agents like ultraviolet radiation, ionizing 
radiation, and several genotoxic chemicals (Ding et al., 2012).  The second leading cause is 
cellular metabolic products, like reactive oxygen species originated from oxidative respiration 
and lipid peroxidation products (Hoeijmakers, 2001) .  Thirdly, some chemical bonds in DNA 
disintegrate under a few physiological conditions, like hydrolysis of nucleotide residues, which 
leaves non-instructive abasic sites; for example, deamination of cytosine is converted to the 
miscoding uracil (Chatterjee and Walker, 2017).  DNA lesions may sometimes also occur due to 
replication errors caused by tautomeric shifts (the "imino" or "enol" form of nucleotides), 
eventually resulting in base-pair mismatching such as an A with a G instead of a T (Tubbs and 
Nussenzweig, 2017) (Figure 5). 
DNA damage response pathways and DNA repair proteins are utilized by the cell to 
repair, remove, or tolerate a variety of DNA lesions, to limit the genomic instability 
(Hoeijmakers, 2001) . As there are different types of DNA lesions, a single repair process cannot 
mitigate all the classes of DNA damage.  At least five main DDR pathways function in mammals:  





Figure 5. DNA damage and repair mechanisms.  At the top, various DNA damaging agents, 
in the middle, examples of DNA lesions caused by these agents, and at the bottom, associated 
DNA repair mechanisms responsible for the removal of the lesions.  cis-Pt, cisplatin; MMC, 
mitomycin C; (6–4)PP, 6–4 photoproduct; CPD, cyclobutane pyrimidine dimer.  Taken from 
(Hoeijmakers, 2001) .
 
repair (BER) reverses oxidative base modifications, homologous recombination (HR) and non-
homologous end-joining (NHEJ) are involved in repair and removal of DSBs through distinct 
mechanisms (Lindahl and Wood, 1999), and mismatch repair (MMR) helps in restoring errors 
that occurred during replication (Jiricny, 2006) (Figure 5).  DDR uses signal sensors, transducers, 
and effectors similar to classic signal transduction pathways (Figure 6) (Zhou and Elledge, 2000). 
Unlike signal transduction pathways activated by ligands of receptor kinases, the DDR 
signaling pathway is activated by anomalous DNA structures (Maréchal and Zou, 2013).  The 
DNA damage signaling pathways are mainly accelerated by the transducers such as ATM (ataxia-
telangiectasia mutated), ATR (ATM- and Rad3-Related), and DNA-PK (DNA-dependent protein 
kinase).  Sensors such as the MRN complex (MRE11, RAD50, and NBS1) detect DSBs, then 
recruit and activate ATM at the lesion site (Ryan et al., 2016).  Activated ATM phosphorylates 
several effector proteins, such as CHK2 (Checkpoint kinase 2), H2AX, 53BP1, and p53. 




by activators, namely RNF8 (Ring Finger Protein 8) and RNF168 E3 ubiquitin ligases, lead to 
the recruitment of DNA repair proteins like BRCA1/pBRCA1 (Turnell and Grand, 2012) 
(Figure 6).  Alternatively, ATR is primarily activated at ssDNA regions first coated by 
the sensor RPA (Replication protein A) (Ball et al., 2005). 
 
Figure 6. The framework of DNA damage response signaling pathways.  Various protein 
complexes acting distinctly as either sensors, transducers, activators, or effectors in ATM, ATR and 
DNA-PK pathways.  The arrows represent the flow of the individual pathways.  Taken from (Turnell 
and Grand, 2012). 
 
Further, ATR is recruited to RPA-coated ssDNA through its interacting protein ATRIP 
(ATR interacting protein) (Namiki and Zou, 2006).  The recruitment of activator TOPBP1 
(Topoisomerase 2 Binding Protein 1) to the ssDNA region is responsible for the ATR activation 
that later phosphorylates effector proteins like CHK1 (Ball et al., 2005).  These effectors 
ultimately result in various cellular responses such as DNA repair, cell cycle arrest, and 
apoptosis.  Unlike the ATM and ATR kinases, DNA-PK is responsible for regulating the NHEJ 




it remains unknown whether DDX41 acts as a DDR sensor, transducer, or effector.  Moreover, 
the mechanism by which DDX41 may potentially produce DDR is an unanswered question. 
 
1.6 R-loops 
R-loops originate during transcription, when nascent RNA exits RNA polymerase, and pairs 
with its complementary DNA template, resulting in RNA:DNA hybrid structure and displaced 
single-stranded DNA (Chakraborty et al., 2018a) (Figure 7).  R-loops are found in many 
organisms where they perform various cellular processes, involving regulation of chromosome 
segregation, replication of bacterial plasmids and mitochondrial genomes (Kabeche et al., 
2018), and accomplishing immunoglobulin class-switch recombination (Aguilera and García-
Muse, 2012).  In mammalian cells, R-loops take up almost 5% of the genome (Ginno et al.,  
 
 
Figure 7. The structure of an R-loop.  ssDNA, single-stranded DNA; RNAP, RNA 
Polymerase.  Taken from (Hamperl and Cimprich, 2014). 
 
2012).  They are abundant at promoter and terminator regions of polyA-dependent genes, which 
implies the potential role of R-loops in the regulation of gene expression (Ginno et al., 2012).  
Further, R-loops are also found in tRNA and rDNA genes, implying their formation through 
transcription involving different RNA Polymerases (Santos-Pereira and Aguilera, 2015). 
Despite the various regulatory role of R-loops, these can also cause a major threat to 
genomic stability if they persists, i.e., generating single-stranded, which can adversely lead to 
stalling or collapsing of replication forks (Basu et al., 2011; Hamperl and Cimprich, 2014; Santos-Pereira 
and Aguilera, 2015) and fatal double-strand DNA breaks by the endonucleases XPF and XPG, 
involved in nucleotide excision repair (NER) pathway. (Sollier et al., 2014).  The R-loops 
formed during transcription are also deciphered to promote the aggravation of DNA damage by 




not exclusively, the machinery of transcription and replication processes results in a collision 
and consequently leads to increased DNA breaks as both the processes utilize the same template 
of DNA (Sanchez et al., 2020) (Figure 8).  Persistent R-loop structures and the TRCs lead to genomic 
instability that prompts various cellular fates (Lang et al., 2017) and diseases in humans, 
including neurodegenerative diseases (Chen et al., 2018; Haeusler et al., 2014; Loomis et al., 
2014) and MDS (Chen et al., 2018).  
Figure 8. Pervasive R-loop formation leads to lethal transcription- replication collisions, a 
major threat to genome stability.  RF, Replication fork; RNAP, RNA polymerase II.  Taken 
from (García-Rubio et al., 2018). 
 
Besides transcription, R-loops are widely associated with DSBs to both induce and inhibit 
DNA repair, depending on whether the R-loops formation is transient or persistent.  A study 
shows that in many instances, induction of DSBs leads to R-loops, which then recruit 
transcription-associated homologous recombination repair (TA-HRR) factors such as RAD52 
and XPG (Kato et al., 2019).  Such mechanisms are crucial for protecting genome integrity, 
particularly in transcriptionally active regions.  Alternatively, R-loops also promote DSB 
formation by activating the ATM associated DDR pathway (Sollier and Cimprich, 2015).  Upon 
the extreme R-loop removal, the efficiency of two central DSB repair pathways, HR and NHEJ, 
was reduced (Lu et al., 2018).  This study led researchers to affirm the importance of R-loop 
structures in promoting DSB repair (Ohle et al., 2016; Yasuhara et al., 2018).  Conversely, as 
mentioned above, persistent and excessive R-loops may challenge the DDR pathway by 
forming pathological DSB and hindering DNA repair in different ways.  In one research study, 




RNA:DNA hybrid (Cerritelli and Crouch, 2009) as well as active ribosomes and anti 
backtracking mechanisms, suppressed DSB accumulation (Dutta et al., 2011), which suggests 
that extension of R-loops is an important cause of DSBs, and in the long run, genome instability 
(Aguilera et al., 2012).  Another consideration is that DSBs formed due to various DNA damage 
sources also induce R-loops, which can trigger both DNA repair or damage depending on 
whether it is moderate and transient or excessive and persistent, respectively (Figure 9).  In the 
former case where R-loops are resolved and DNA is repaired, the process begins with an 
increase in transcription induced at DSB sites (Ohle et al., 2016), leading to a rise in R-loop 
structures.  These structures then recruit DNA repair factors like CSB and carry forward the 
  
Figure 9. Schematic representation of the relationship between double-strand breaks and 
R-loops.  R-loops can be formed as a consequence of DSBs and at situations R-loop formation 
leads to DSBs. In both situations, if excess of either R-loops or DSBs persists due to loss of 
repair proteins and factors, it leads to elevated DNA damage.  CSB, Cockayne syndrome protein 
B.  Modified from (Hegazy et al., 2020). 
 
DDR pathway (Hegazy et al., 2020).  On the other hand, R-loops accumulation and the inability 
Excessive and persistent R-loops








of repair factors to resolve R-loops results in DNA damage, intensification in DSB, and genome 
instability.  Moreover, another research study has revealed that an increase in R-loop formation 
explains how the mechanism of mutations in splicing factors leads to MDS; in particular, 
mutations in splicing factors SRSF2 and U2AF35 augment R-loop formation at gene promoters 
(Chen et al., 2018). 
Various proteins hold vital positions to resolve R-loop structures, which may otherwise lead 
to secondary pathological structures, mutagenesis, DNA damage-inducing TRCs.  FANCA and 
FANCD2 (Fanconi anemia pathway factors) (Gaillard et al., 2015; Schwab et al., 2015) 
DNA/RNA helicases and various types of RNase H (Kim and Jinks-Robertson, 2012) are some of 
them.  Interestingly, a recent study using zebrafish showed that depletion or mutation of DDX41 
caused the accumulation of R-loops, which triggered the inflammatory signals and caused 
increased production of hematopoietic stem and progenitor cells (HSPCs) (Weinreb et al., 2021).  
Thus, DDX41 appears as a potential co-transcriptional DDR protein that might resolve R-loops 
and avoid TRCs to maintain genome stability and prevent the occurrence of MDS and AML 
pathogenesis. 
 
2. HYPOTHESIS AND OBJECTIVES 
2.1 Hypothesis 
       DDX41 is required for efficient DNA damage response and R-loop resolution to maintain 
genome stability. 
 
2.2  Objectives 
1. Determine the potential role of DDX41 in DNA damage response. 
 
2. Determine the mechanisms of DDX41 in DNA repair response. 
 
3. Determine co-localization of DDX41 with DNA double-strand break marker, transcription 
machinery, and R-loop in cells using confocal microscopy. 
4. Examine the levels of RNA:DNA hybrid in DDX41 KO cells-reconstituted with DDX41-





3.1 Plasmid DNA 
DDX41 (both full-length) was PCR amplified and cloned into the Hind III and BamH I sites 
of a pAcGFP1-N2 vector (Clontech). All point mutations were generated with a QuikChange 
Site-Directed Mutagenesis Kit (Agilent Technologies). 
For CRISPR-knockout, four sgRNAs used targeting exons 2 and 3 of the human 
DDX41 gene were designed with http://crispr.mit.edu, the pair of DNA oligonucleotides were 
synthesized by IDT, then annealed and ligated into the Bbs I site of pSpCas9(BB)-2A-Puro 
(pX459) vector (#62988, Addgene), as described (Ran et al., 2013). The insert was confirmed 
with Age I and Bbs I digestion.  LentiCRISPR v2 plasmids targeting the DDX41 gene were 
constructed using methods as described (Sanjana et al., 2014).  All plasmids were verified by 
DNA sequencing. 
 
3.2 Cell lines 
HeLa and HT1080 cells (from ATCC) were grown in DMEM supplemented with 10% 
FBS with  penicillin and streptomycin (100 U/mL each, Sigma-Aldrich).  CRISPR DDX41 
knockout HeLa and HT1080 cell lines were generated by Dr. Ravi Shankar Singh (Post-doc) 
in Dr. Yuliang Wu’s lab (University of Saskatchewan); Next, lentivirus overexpression of 
DDX41-WT and DDX41-R525H gene in wildtype and DDX41-KO background cells have also 
been established by Dr. Ravi Shankar Singh; To overexpress both WT and R525H DDX41 in 
DDX41 KO or WT cell lines, DDX41 gene was cloned into Kpn I and Not I sites of the entry 
vector pEN_TTmcs (25755, Addgene), and transferred to the destination vector pSLIK Hygro 
( 25737, Addgene) by the Gateway system .  The lentivirus particles were prepared as 
described above, and the expression of DDX41 was induced by doxycycline 20 ng/mL, 
Invitrogen 
 
3.3 CRISPR knockout 
For both HT1080 and HeLa cells transfection, 1×106 cells were seeded in a 6-well plate 24 h 
before transfection. Two μg of DNA was transfected to each well using Lipofectamine 3000 




5 μg/mL puromycin (Sigma) and maintained in selection medium until clones were visible. 
The clones were picked individually and grown in 6-well plates until confluency, with the 
cells lysed using RIPA buffer (25 mM Tris, pH 7.4; 150 mM NaCl; 0.5% sodium 
deoxycholate; 1% NP-40) with 2 mM phenylmethylsulfonyl fluoride (PMSF) and protease 
inhibitor cocktail (Sigma). The gene KO was confirmed by Western blot analysis, followed by 
PCR amplification of the target segment, and cloning into TOPO-TA vector (Invitrogen) for 
sequencing. 
 
3.4  Reagents 
Table 1. List of reagents, catalog number and suppliers 
Reagents, Cat No. Suppliers Address 
Acrylamide, 0314 AMRESCO North York, Ontario, Canada 
N,N'-Methylenebisacrylamide, 
AC164790250hrp 
Fisher Scientific Madison, Wisconsin, USA 
Adenosine Triphosphate 
(ATP), A1852 
Sigma-Aldrich Oakville, Ontario, Canada 
 
Clarity Max Western ECL 
substrate, 1705062 
Bio-Rad Laboratories, Inc. Mississauga, Ontario, 
Canada 
Agarose，5510UB Gibco Burlington, Ontario, Canada 
Ampicillin, A1593 Sigma-Aldrich Oakville, Ontario, Canada 
Ammonium persulfate (APS), 
A3678 
Sigma-Aldrich Oakville, Ontario, Canada 
Boric acid, SLBC5554V Sigma-Aldrich Oakville, Ontario, Canada 
Bovine serum albumin, A2058 Sigma-Aldrich Oakville, Ontario, Canada 
Bradford protein assay reagent, 
500-0013 
Bio-Rad Hercules, California, USA 
Bromophenol blue, B0126 Sigma-Aldrich Oakville, Ontario, Canada 
Chloramphenicol, 
AC227920250 
Fisher Scientific Madison, Wisconsin, USA 
Dithiothreitol (DDT), 
10197777001 
Sigma-Aldrich Oakville, Ontario, Canada 
Dulbecco's Modified Eagle 
Medium (DMEM), 
SH30022.01 
Sigma-Aldrich Oakville, Ontario, Canada 
EDTA, 17892 Fisher Scientific Madison, Wisconsin, USA 
Fetal Bovine Serum (FBS), 
F6178 
Sigma-Aldrich Oakville, Ontario, Canada 
[γ-32P] ATP, BLU502A Perkin Elmer Boston, MA, USA 
Glycine, BP381-5 Fisher Scientific Madison, Wisconsin, USA 








Fisher Scientific Madison, Wisconsin, USA 
Kanamycin, 60615 Fisher Scientific Madison, Wisconsin, USA 
Lysogeny Broth (LB) with 
agar, L2897 
Sigma-Aldrich Oakville, Ontario, Canada 
Methanol, 154246 Sigma-Aldrich Oakville, Ontario, Canada 
Magnesium chloride (MgCl2), 
M8266 
Sigma-Aldrich Oakville, Ontario, Canada 
Nickel-NTA Affinity beads, 
70666 
Sigma-Aldrich Oakville, Ontario, Canada 








Sigma-Aldrich Oakville, Ontario, Canada 
Polyethyleneimine (PEI) 
MAX, 24765 
Polysciences, Inc. Warrington, Pennsylvania 
Phenylmethylsulfonyl fluoride 
(PMSF), P7626 
Sigma-Aldrich Oakville, Ontario, Canada 
Protein standard, 161-0374 Bio-Rad Hercules, California, USA 
Protease inhibitor, 
05892791001 
Roche Mannheim, Germany 
Polyvinylidene difluoride 
membrane (PVDF), 10600023 
Bio-rad Mississauga, Ontario, 
Canada 
Sodium dodecyl sulfate (SDS), 
L3771 
Sigma-Aldrich Oakville, Ontario, Canada 
Sodium chloride (NaCl), S671-
10 
Fisher Scientific Madison, Wisconsin, USA 
Thiamine hydrochloride, 
T4625 
Sigma-Aldrich Oakville, Ontario, Canada 
Tris, 0826 AMRESCO North York, Ontario, Canada 
Tris (2-carboxyethyl) 
phosphine, C4706 
Sigma-Aldrich Oakville, Ontario, Canada 
TritonTMX-100, X100 Sigma-Aldrich Oakville, Ontario, Canada 
Trypsin-EDTA, T4049 Sigma-Aldrich Oakville, Ontario, Canada 
Tryptone, TRP402.205 BioShop Burlington, Ontario, Canada 
TWEEN 20, BP337 Fisher Scientific Madison, Wisconsin, USA 
 
3.5 DNA damage treatments 




well plate using a cell counter and incubated at 37˚C, 5% CO2 for 16 hours in 2 mL of DMEM 
medium.  After 16 hours, DNA damage was induced by exposure to 5 Gy ionizing radiation 
(IR produced by X-Rad225 XL, Precision X-Ray), 10 mM hydroxyurea (HU, VWR cat # 
CAAAA10831-03) for 16 h, 50 J/m2 of UV radiation, or 30 μg/mL of Bm (Bleomycin sulphate, 
Bioshop cat# BLE011.10) for 16 hours. 
 
3.6 Antibodies 
DDX41 mouse antibody (MABF1107) from Sigma-Aldrich was used for certain 
immunofluorescence imaging, and DDX41 rabbit antibody (D3F1Z) from New England 
Biolabs (NEB) was used for both immunofluorescence imaging and immunoblotting, which 
recognizes the N-terminal of DDX41 (98 amino acid of DDX41).  γH2AX (Ser139, 20E3), 
phosphor- BRCA1 (Ser1524, 9009), and 53BP1 antibodies (E7N5D) were from NEB.  S9.6 
antibody was from Kerafast (ENH001).  Double-stranded DNA antibody (ab27156) and RNA 
polymerase II antibody (ab817) were from Abcam.  β-actin-HRP conjugated mouse antibody 
(sc-47778 HRP) was from Santa-Cruz.  Goat anti-rabbit IgG HRP-conjugated (7074) and goat 
anti-mouse IgG HRP-conjugated (7076) secondary antibodies were from NEB.  
Immunofluorescence secondary antibodies, IgG (H+L) highly cross-adsorbed goat anti-rabbit 




3.7 Confocal microscopy 
Cells seeded onto coverslips in a 6-well plate were washed twice with PBS and fixed with 
100% methanol at -20°C for 30 min, then washed with PBS and blocked with blocking buffer 
(1% BSA in PBST, PBS+0.1% Tween 20) at room temperature for 1 h.  The immunostaining 
was performed by incubating cells with primary antibodies (1:100) in blocking buffer 
overnight at 4°C.  After washing with 1 mL of PBS (thrice), the cells were incubated with 
secondary antibodies, Alexa Fluor 488 goat anti-rabbit IgG (1:1000, Invitrogen), and Alexa 
Fluor 594 goat anti-mouse IgG (1:1000, Invitrogen) in blocking buffer for 1 h at room 
temperature.  Cells were then washed with 1 mL of PBS (thrice) and mounted with Prolong 




dark for 16-20 hours.  Immunofluorescence was performed on a Zeiss LSM 700 META 
inverted Axiovert 200 M laser scan microscope with a Plan-Apochromat 63×/1.4 oil DIC 
objective.  Images were captured with a CCD camera and analyzed using LSM Browser 
software ZEN (Zeiss). 
For GFP tagged proteins, cells were directly fixed with methanol, mounted with 
Prolong Diamond antifade reagent containing DAPI and then observed under an LSM 700 
microscope. 
 
3.8 Western blotting 
Depending on the size of the target protein, proteins were separated on 6, 8, 10, 12, or 15% 
SDS- polyacrylamide gel using Tris-glycine buffer (with 10 % SDS).  After electrophoresis, 
the proteins were transferred to a PVDF membrane (Bio-Rad) using Wet/Tank blotting system  
in the transfer buffer (25 mM Tris, 192 mM glycine, pH 8.3, and 20% methanol) at 100 V for 
3 h at 4°C.  The membrane was incubated with blocking buffer (5% BSA in PBST) for 1 h at 
room temperature.  The membrane was then incubated in the primary antibodies of interest 
(1:1000, prepared with 1% BSA in PBST) at 4°C, for 16 hours.  After washing with 5 mL of 
PBST five times (5 min each), the membrane was incubated with HRP conjugated secondary 
antibody (1:5000, NEB) with 1% BSA in 5 mL of PBST for 1 h at room temperature; then 
washed three times with 5 mL of PBST (5 min each).  The membrane was then treated with 
Clarity Western ECL Substrate (Bio-Rad) and visualized using a ChemiDoc MP Imaging 
System (Bio-Rad). 
 
3.9 Alkaline comet assays 
An alkaline comet assay was performed using a CometAssay kit (R&D systems, cat# 4250-050-
K) according to the manufacturer's instructions. Briefly, 2 x 104 cells/mL were seeded in 6-well 
plates using a cell counter and incubated at 37˚C, 5% CO2 for 16 hours in DMEM medium, and 
treated the next day with bleomycin (30 μg/mL, 16 hours) and collected at different time points, 
post-treatment.  Cells were washed with 1 mL of PBS and centrifuged at 4000 rpm for 5 mins, 
and the pellet was mixed with 50 µL of PBS and 500 µL of molten low-melting-point agarose 




precoated with agarose and incubated at 4°C for 30 min in the dark (to avoid any further DNA 
damage in the cells).  To unwind the supercoiled DNA, cells were lysed using the CometAssay 
Lysis Solution (from the CometAssay kit) for 1 h at room temperature in the dark and then 
exposed to an alkaline solution (pH >13) for 20 min at room temperature in the dark.  Next, the 
electrophoresis was performed using Horizontal Electrophoresis System from Bio-Rad at 21 
volts for 30 min, where the DNA-strand breaks present in the cells migrate in the direction of 
the anode.  Finally, the slides were washed with water, fixed with 70% ethanol for 15 min, and 
then stained with GelRed (Biotium) for 30 min at room temperature in the dark.  DNA was 
visualized under a confocal microscope (Zeiss LSM 700) at a 20× magnification.  The open-
source software ImageJ (https://imagej.nih.gov/ij) was used to measure the tail length. 
 
3.10 Dot blot assays 
On day 1, cells (5 X 106) were collected and lysed in 1 mL lysis buffer, composed of 500 µL 
2× lysis buffer (0.5% SDS, 40 mM Tris-HCl pH 7.5, 150 mM NaCl, and 5 mM EDTA), 500 µL 
2x TE (100 mM Tris-HCl pH 8, 10 mM EDTA pH 8), and 10 uL of proteinase K (20 mg/ml), 
at 37°C for 16 hours.  Genomic DNA was then extracted using DNeasy Blood & Tissue Kit 
(Cat # 69506, Qiagen) and samples of extracted DNA (~50 µg each) fragmented using a 
restriction enzyme cocktail of 1 µL HindIII (20 U/µL), 1 µL EcoRI (20 U/µL), 2 µL BsrGI (10 
U/µL), 1 µL XbaI (20 U/µL), and 4 µL SspI (5 U/µL, all from NEB) in NEB Buffer 2 (in 300 
µL total) at 37°C for overnight.  On day 3, the mixture was treated with 2 U of RNase III (NEB) 
and 4 U of RNase T1 (Fisher) for 2 h.  The digested fragments were divided into two parts: one 
was treated with 4 U of RNase H for 2 h, and another remained untreated.  The fragmented 
DNA samples were repurified using the DNeasy Blood & Tissue Kit and dissolved in 100 µL 
of 5 mM Tris-HCl pH 8.5. The extracted DNA was quantified using a Nanodrop (Thermo 
Fisher).  Each sample was diluted to 250 ng in 50 µL of TE and was spotted on a nylon 
membrane and crosslinked by UV treatment.  The membrane was blocked with 5% milk in 10 
mL of PBST and incubated with S9.6 antibody (1: 2000 dilution in 3% BSA of PBST) for 16 
hours at 4°C.  The membrane was then washed five times with 10 mL of PBST and incubated 
with secondary antibody (1: 1000 dilution in 3% BSA of PBST) for 1 h, and later the membrane 
was treated with ECL reagent (Bio-Rad) and visualized using a ChemiDoc MP Imaging System 




(15 mg/mL glycine, 1 mg/mL SDS, and 1% Tween 20, pH 2.2), re-blocked with 10 mL of 5% 
BSA in PBST for 1 hour, and then incubated with dsDNA antibody (1:2000 dilution in 3% BSA 
of PBST) for 1 h and then washed and next incubated with secondary antibody (1: 1000 dilution 
in 3% BSA of PBST) for 1 h. After three times of washing with 10 mL of PBST for 5 minutes 
each, the nylon membrane was visualized by the ChemiDoc MP Imaging System. 
 
3.11 Recombinant proteins 
The plasmid containing pDEST17-DDX41-WT or pDEST17-DDX41-R525H mutant was 
transformed into E. coli Rosetta 2 cells (DE3, EMD Millipore).  The cells were grown at 37°C in 
1 L of LB medium containing 100 μg/mL  of ampicillin and 34 μg/mL of chloramphenicol until 
an OD600 was reached 0.6.  Cells were then induced with 0.3 mM IPTG for 16 hours at 15°C.  
The cells were harvested by centrifugation at 5000 g for 10 min at 4 °C.  The periplasmic 
material was removed from the cells as described (Magnusdottir et al., 2009).  Briefly, the cells 
were suspended in 5 mL/g (cell mass) of hypertonic buffer (50 mM HEPES, pH 7.4, 20% 
sucrose, and 1 mM EDTA) on ice for 30 min and centrifuged at 8000 g for 10 min at 4 °C.  The 
cells were re-suspended in 5 mL/g of cell mass with hypotonic solution (5 mM MgSO4) and 
incubated for 10 min on ice.  Cells were then pelleted by centrifugation at 4000 g for 10 min at 
4 °C and stored at -80 °C until use.  The cells were lysed by sonication in buffer A (50 mM 
HEPES-NaOH, pH 7.0, 300 mM NaCl, 20 mM imidazole, 10% glycerol, 2 mM MgCl2, and 5 
mM β-mercaptoethanol) with a final concentration of 1 mM PMSF and 10μL of 100x protease 
inhibitor (Roche Applied Science) at 4 °C, with 10 short bursts of 10 s at intervals of 10 min.  
The cell debris and inclusion bodies were removed by centrifugation at 45,000 g for 30 min at 4 
°C.  Recombinant His-tagged DDX41 proteins were subjected to a two-step purification 
involving Nickel Affinity beads (Sigma-Aldrich) and a Sephacryl S-300 HR 16/60 gel filtration 
column (GE Healthcare).  The supernatant was applied to the Ni-NTA beads equilibrated with 
buffer A, washed with 10 column volumes (CVs) of buffer  B (50 mM HEPES-NaOH, pH 7.0, 
150 mM NaCl, 10% glycerol, 2 mM MgCl2, a n d  5 mM β-mercaptoethanol) containing 
20 mM imidazole, and proteins were eluted with 5 CVs of buffer C (50 mM HEPES-NaOH, 
pH 7.0, 300 mM NaCl, 10% glycerol, 2 mM MgCl2, 5 mM β-mercaptoethanol, and 500 mM 
imidazole).  The composition of protein fractions were evaluated by SDS-PAGE, and  the 




chromatography on a Sephacryl S-300 HR 16/60 column (GE Healthcare) that was equilibrated 
and eluted with buffer D (50 mM HEPES-NaOH, pH 7.0, 150 mM NaCl, 10% glycerol, 2 mM 
MgCl2, and 1 mM DTT).  The fractions were collected at a flow rate of 0.5 mL/min with the 
same buffer.  The protein composition of each peak was assessed by SDS-PAGE, and the 
fractions of interest were pooled and concentrated. 
All proteins were snap-frozen in liquid nitrogen and stored at -80°C.  Protein 
concentration  was determined by the Bradford method (Bradford, 1976) using bovine serum 
albumin (BSA) as the standard. 
 
3.12 RNA and DNA substrates 
PAGE-purified oligonucleotides were purchased from Integrated DNA Technologies (IDT): 
RNA 30 mer: 5’-GAGCTACCAGCTACCCCGTATGTCAGAGAG-3’ and  
DNA 30 mer comp+15T: 
5’-CTCTCTGACATACGGGGTAGCTGGTAGCTCTTTTTTTTTTTTTTTTTTTTTTTTT-
3’ 
A single oligonucleotide for each substrate was 5′-end-labeled with [γ-32P] ATP (Perkin Elmer) 
at 37°C using T4 polynucleotide kinase (NEB) for 1 h.  Unbound radionucleotides were 
removed by using a G25 chromatography column (GE Healthcare).  For the RNA:DNA hybrid 
substrate, an [γ-32P]ATP-labeled oligonucleotide was annealed to a 2.5-fold excess of the 
unlabeled complementary strands in annealing buffer (10 mM Tris–HCl, pH 7.5, 50 mM NaCl) 
by heating at 95°C for 5 min and then cooling slowly to room temperature.  The annealed 
RNA:DNA substrates were stored at 4°C until used. 
 
3.13  Helicase assays 
Helicase assay reaction mixtures (20 μL) comprised 40 mM Tris (pH 8.0), 0.5 mM MgCl2, 15 
mM NaCl, 0.01% Nonidet P-40, 0.1 mM DTT, 1 mg/mL BSA, an equimolar mixture of 2 mM 
ATP and MgCl2, 0.5 nM of RNA:DNA substrate, and the indicated concentrations of DDX41 
protein.  Helicase reactions were initiated by adding DDX41 protein and then incubated at 




mM EDTA, 0.3% SDS, 12.5% glycerol, 0.02% bromphenol blue, and 0.02% xylene cyanol).  
A 10-fold excess of unlabeled oligonucleotide (cold oligo that has the same sequence as the [γ-
32P]ATP labelled strand) was included in the quench to prevent reannealing.  The products of 
the helicase reactions were resolved on nondenaturing 15% (19:1 acrylamide: bisacrylamide) 
polyacrylamide gels.  32P-radiolabeled DNA or RNA species in polyacrylamide gels were 
visualized using Phosphor-Imager Typhoon FLA 7000 (GE Healthcare). 
 
3.14 Strand annealing assays 
A 20ul reaction was carried out with 0.5 nM of RNA:DNA hybrid substrate.  The substrate was 
first denatured at 100°C for 5 min and then incubated with 0 to 3 μM of DDX41 protein at 37˚C 
for 15 min with or without 2 mM ATP in the helicase assay buffer (see above).  After incubation, 
the reaction was stopped by addition of 20 μL of 2×Stop buffer (17.5 mM EDTA, 0.3% SDS, 
12.5% glycerol, 0.02% bromophenol blue, and 0.02% xylene cyanol).  The mixture was resolved 
on 15% native PAGE gel for 2 h at 180 V.  The resolved radiolabeled species were visualized 
using the Phosphor-Imager Typhoon FLA 7000. 
 
4. RESULTS 
4.1 DDX41 forms foci upon IR exposure 
To investigate the potential role of DDX41 in DNA damage response, I examined the ability of 
both endogenous (Figure 10) and exogenously expressed (Figure 11) (tagged with GFP) 
DDX41, to form foci in response to IR (ionizing radiation, 2 Gy) in HT1080 cells.  In this work 
I largely address biological DNA damage and evaluated by measuring the foci yields.  These 
subnuclear foci are formed upon various DNA damage related response factors, which accumulate 
explicitly at damaged sites, are spotted as distinct spots in nuclei (Rothkamm et al., 2015). IR directly 
affects DNA structure by inducing DNA breaks, particularly DSBs (Cannan and Pederson, 2016).  
DDX41 foci formation appeared after IR treatment, and the number of foci per cell increased 
over 4 h, i.e., an average of 5 at 0.5 h to 35 at 4 h of IR treatment (Figure 10B and D).  In this 
experiment, IgG (Figure 10A) and γH2AX (Figure 10C) were used as negative and positive 
controls, respectively.  As expected, no foci were formed in the IgG panel throughout the time 




treatment (Figure 10A and D).  Next, I performed confocal imaging of exogenous DDX41 over 
4 h after IR treatment to check any IR-induced foci formed.  Here, Bloom helicase, which is a 
well-known DNA repair protein (Patel et al., 2017), was used as a positive control (Figure 
11D).  GFP vector (Figure 11B) and DDX41-K9A (Figure 11C) mutant (only localizes in the 
cytoplasm) acted as negative controls.  I found that there was a 2-fold increase in the number 
of DDX41 foci from 0.5 h to 4 h (Figure 11 A and E).  There was no foci formation observed 
in cells harbouring the  GFP vector and DDX41-K9A. To elaborate, GFP vector was found both 
in cytoplasm and nucleus, without any specific localization and foci formation.  Additionally, 
DDX41-K9A was predominantly localized in the cytoplasm and did not result in any IR-
induced foci.  Furthermore, Bloom helicase showed increased in foci over time, at 0 h the foci 
were minimal (i.e., 2 at an average), whereas it gradually increased to 6 times (relative to 0 h) 
by 4 h of IR treatment.  Hence, these results suggest a possible role of DDX41 in DDR. 
 
Figure 10. IR induced foci formation of DDX41 in HT1080 cells.  Immunofluorescence of 
(A) IgG (negative control), (B) DDX41, and (C) γH2AX (positive control), over time course 
of 0, 0.5, 1, 2, and 4 h after exposure to ionizing radiation in HT1080 cells. Nuclear DNA was 
counterstained with DAPI.  (D) Quantitative analysis of foci from 100 cells shown in panels 














































Figure 11. IR induced foci formation of DDX41-GFP in HT1080 cells.  
Immunofluorescence of (A) GFP-DDX41-WT, (B) GFP vector (negative control), (C) GFP-
DDX41-K9A (mutant, negative control), (D) GFP-Bloom (positive control), over time course 
of 0, 0.5, 1, 2, and 4 h in HT1080 cells after exposure to 2 Gy of ionizing radiation.  Nuclear 
DNA was counterstained with DAPI.  (E) Quantitative analysis of foci from 100 cells shown 
in panels A-D in three biological replicates ±SD.  
 
4.2 DDX41 is involved in the DNA damage response pathway  
To confirm the role of DDX41 in DDR and DNA repair, I performed immunoblotting to 
visualize some DDR related proteins (γH2AX, 53BP1, p-CHK2, p-BRCA1, p-ATM, and p-P53) 
in both wildtype (WT) and DDX41-KO cell lines before and after treatment with IR (Figure 
12A) or HU (Figure 12B) DNA damage for a time course of 24 h.  Besides IR, I also included 
hydroxyurea (HU), which is used to model DNA damage by depleting the cells of dNTPs and resulting 
in stalled replication forks (Gottmann et al., 2010). I found that the levels of DNA damage proteins, 
















































Figure 12. Altered protein levels are linked to DNA damage response in DDX41 KO.  (A 
and B) Immunoblot analysis of DDR protein levels in WT and DDX41 KO HT1080 cells after 
IR (A, 5 Gy) and HU (B,10 mM) treatment. β actin serves as a loading control.  (C) Confocal 
images of γH2AX foci in WT and DDX41-KO cells after 5 Gy IR treatment, and collected at 
different time points i.e., at 15 min (1/4, 0.25 h), 1, 2, 4, 8, 24 h.  (D) Quantification data of foci 
from 100 cells shown in panel C in three biological replicates ±SD.  M, marker; UT, untreated; 
WT, wildtype; DDX41-KO, DDX41-knockout. 
 
the γH2AX and 53BP1 level was comparatively higher and prolonged up to 24 h (Figure 12A 
and B).  Additionally, the phosphorylation of DNA repair signaling protein, BRCA1 to 
pBRCA1 (Ser1524, DNA damage-induced phosphorylation site on BRCA1) was delayed and 
diminished in DDX41-KO cells.  To elaborate, the damaged DNA repair process indicated by 
phosphorylation of BRCA1 initiated within 0.5 h after the DNA damage in WT cells, but the 
phospho-levels of BRCA1 were weak and appeared later around 8 h in the KO cell lines.  



















































I further verified these results by confocal imaging.  I found that IR-induced γ-H2AX 
protein foci were observed up to 24 h in DDX41-KO cells, compared to 4 h in WT cells 
(Figure 12C and D), indicating that delayed or impaired DSB repair maybe related to DDX41 
loss.  To investigate the time at which DNA damage is resolved, I increased the investigation 
time to 72 h.  I observed that the DNA damage indicated by γ-H2AX and 53BP1 levels was not 
resolved until 24 h after treatment in KO cells.  In contrast, the DNA damage dissipated after 
4 h in WT cells, suggesting that damaged DNA was repaired earlier in the presence of DDX41 
(Figure 13).  These data suggested DDX41 is required for DNA damage repair, and loss of 




Figure 13. Prolonged DNA damage in DDX41 KO cells.  Western blots showing protein 
levels of 53BP1 and γ-H2AX in WT and DDX41-KO HT1080 cells at different time points, 
i.e., at 0.25, 0.5, 1, 2, 4, 8, 24, 32, 64, and 72 h, after IR treatment.  M, marker; UT, untreated; 
WT, wildtype; DDX41-KO, DDX41-knockout. 
 
4.3 Increased DNA damage in DDX41-knockout cells 
To verify the results above, I treated cells with additional DNA damage treatments, including 
IR, HU, and UV.  UV radiation causes two classes of DNA lesions: cyclobutane pyrimidine 
dimers and 6-4 photoproducts (Kemp and Sancar, 2012).  Immunoblots of WT and  
DDX41-/- HT1080 (Figure 14) and HeLa (Figure 15) cell lines after IR (Figure 14A and 
15A), UV (Figure 14B and 15B), or HU (Figure 14C and 15C) were performed to examine 
the DDR-related protein levels up to 72 h post-treatment.  In agreement with the results 
described above, I found γH2AX and 53BP1 levels were increased and prolonged in both 









Figure 14. Impaired DNA damage response in DDX41-knockout HT1080 cells.  Western 
blot assays of DDR-related proteins in WT and DDX41-/- HT1080 cell lines after (A) IR (5 
Gy), (B) UV (50J/m2), and (C) HU (10 mM for overnight) treatment at various time points 
(UT, 0.25, 0.5, 1, 2, 4, 8, 24, 32, 64, and 72 h) in three biological replicates.  β-actin serves as 
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Figure 15. Impaired DNA damage response in DDX41-knockout HeLa cells.  Western blot 
assays of DDR-related proteins in WT and DDX41-/- HeLa cell lines after (A) IR (5 Gy), (B) UV 
(50J/m2), and (C) HU (10 mM for overnight) treatment at various time points (UT, 0.25, 0.5, 1, 2, 
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53BP1 was majorly mirrored by the levels of pBRCA1 for a period of 1-4 h in WT cells 
compared to 24-64 h in KO cells, suggesting the significance of DDX41 in early DNA 
damage repair.  Taken together, these results implied the crucial role of DDX41 in DDR and 
DSB repair. 
 
4.4 DDX41 co-localizes with DNA double-strand break marker γH2AX 
To further investigate whether DDX41 is directly involved in DDR, I used confocal imaging to 
determine if DDX41 and γH2AX co-localize following DNA damage.  Because the IR machine 
used in above experiments was out of order for later experiments, I used bleomycin (Bm) to 
generate DSB. Bleomycin is a radiomimetic agent that causes DNA strand breaks, such as DSB 
(Chen et al., 2008).  Intriguingly, I observed colocalization of DDX41 (green) and γH2AX (red), 
ranging from 0.5 h to 2-4 h in both HT1080 (Figure 16A and B) and HeLa (Figure 16D and 
E) cell lines after Bm (30 μg/ml, overnight) treatment.  Additionally, the colocalization 
experiment also confirmed that Bm-induced γH2AX foci were higher and prolonged (up to 24 
h) in DDX41 KO cells than WT cells (Figure 16A, B, D, and E).  On average, 10-12 foci/cell 
were persistent in KO cell lines, whereas 1-2 foci/cell were detectable in WT cells after 24 h of 
DNA damage treatment (Figure 16C and F).  Collectively, these results suggested that DDX41 
might colocalize at DSB sites and participate in the DNA repair process along with other 















































































































Figure 16. DDX41 colocalizes with γH2AX upon DNA insult.  (A and D) 
Immunofluorescence staining of WT and DDX41-/- (A) HT1080 and (D) HeLa cells with 
γH2AX (red), DDX41 (green), and DAPI (blue) at various time points (0, 0.5, 1, 2, 4, and 24 h) 
after Bm (30 μg/mL, overnight) treatment in three biological replicates.  Quantitative analysis 
of the percentage colocalization of γH2AX and DDX41 after Bm treatment in HT1080 (B) and 
HeLa (E) cells.  Quantitative analysis of the number of γH2AX foci after Bm treatment in 
HT1080 (C) and HeLa (F) cells. The number of cells analyzed per channel are 100.  Error bars 































































































4.5 Comet assay validates higher and prolonged DNA damage in DDX41-KO 
cells 
Next, I performed an alkaline comet assay to measure the DNA breaks formed in cells 
expressing or lacking DDX41 (Langie et al., 2015).  Here, I estimated the amount of migrated 
DNA, revealed by the tail length indicating the extent of DNA damage in the cells (Figure 17).  
The untreated cells of both WT and DDX41-KO did not show any migration.  However, 
DDX41-KO cells displayed higher migration than WT cells over 4 h after Bm treatment.  In 
addition, this migration extended up  
 
Figure 17. Alkaline comet assay showing higher and prolonged DNA migration in DDX41-
KO HT1080 cells.  (A) Staining DNA in WT and DDX41-/- cells at various time points 
(0/untreated, 0.5, 1, 2, 4, and 24 h) after Bm (30 μg/ml, overnight) treatment in three biological 
replicates  (B) Quantitative analysis of tail length (µm) (indicative of the damaged DNA) of 
the cells shown in panel A.  Migration of comet tails of random 50 cells were measured by 
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to 24 h in KO cells, whereas this was resolved after 4 h of DNA damage in the WT cells (Figure 
17A and B).  The analysis of the tail length for WT cells demonstrates approximately 40-80% 
of the relative DNA migration, whereas, in DDX41-KO, this range grew to 80-100% over the 
time course after the Bm treatment.  Moreover, after 24 hr of the DNA insult, the damaged 
DNA was recovered in the WT cells, i.e., the DNA migration was negligible, around 13%.  In 
contrast, the DDX41-KO still showed significant unrecovered DNA damage, revealed by 
around 40% of the tail length (Figure 17B).  Hence, the results of the alkaline comet assays 
were consistent with my previous Western blot and immunofluorescence results and confirmed 
that greater and persistent DNA damage occurs in DDX41 KO cells. 
 
4.6 DDX41 promotes RNA:DNA hybrid clearance 
Preliminary data in Dr. Wu’s lab has shown that DDX41 protein binds and unwinds RNA:DNA 
hybrids in vitro, a part of the R-loop structure.  Based on this, I wanted to determine the role of 
DDX41 in R-loop formation in cells.  To address this, I performed dot blot assays for various 
time points (i.e., 0.25, 0.5, 1, 2, and 4 h) after DNA damage treatment in WT and DDX41-KO 
HT1080 cells.  I used three different DNA damages, i.e., UV, HU, and Bm, and deciphered the 
levels of R-loops by dot blotting.  To determine the R-loop structures in the cells and on the 
membrane, the antibody S9.6 was used. S9.6 is a gold standard antibody that is used to 
specifically detect RNA:DNA hybrids (Smolka et al., 2021). RNase H was used to degrade the 
RNA molecules in the RNA:DNA hybrid, serving as a negative control in the experiment.  
Furthermore, dsDNA was used as a loading control.  As expected, RNase H degraded all R-loops 
in our samples.  DDX41-KO cells treated with Bm (Figure 18A), UV (Figure 18B), or HU 
(Figure 18C) exhibited higher and prolonged R-loop structures, when compared to the wild type 
that resolves.  To elaborate, upon Bm, UV, and HU treatment, both HT1080 WT and DDX41-
KO cells exhibited R-loop formation.  Here, in both the cell lines R-loops began to appear early 
in 0.25 h and increased by 0.5 h after the treatment.  The WT cells resolved these hybrid 
structures within 1 h, on the other hand, in DDX41-KO cells these hybrids increased and 
accumulated up to 2 h and started delayed resolving at 4 h (Figure 18A).  These results led me 






Figure 18. Dot blot assays showing increased and prolonged RNA:DNA hybrids in DDX41-
KO cells.  Dot blot assays using S9.6 antibody to detect R-loops in HT1080 (WT and DDX41-
KO) cells at different time points (UT, 0.25, 0.5, 1, 2, and 4 h) after Bm (30 μg/mL, 16 h, A), UV 
(50 J/m2, B), and HU (10 mM for 16 h, C) treatments in three biological replicates.  dsDNA 
antibody was used as a loading control.  UT, untreated. 
 
4.7 Purification of DDX41-WT and DDX41-R525H mutant proteins 
To investigate the molecular pathogenesis of patient mutation R525H, I expressed and purified 
DDX41-WT and DDX41-R525H proteins.  After the Ni-NTA purification, DDX41-WT 
(Figure 19A- C) and DDX41-R525H (Figure 19-F) were purified to near homogeneity using 
size-exclusion chromatography on a Sephacryl S-300 HR 16/60 column.  According to the 
molecular weight standards used to calibrate the size exclusion column, the molecular mass of 
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Figure 19. Purification of DDX41 proteins.  (A and D) SDS-PAGE analysis of the eluted 
DDX41-WT (A) and DDX41-R525H (D) fractions from a Ni-NTA column.  M, marker.  Eluted 
fractions 4-20 are shown.  (B and E) Chromatographic profiles of recombinant DDX41-WT 
(B) and DDX41-R525H (E) proteins eluted from a Sephacryl S-300 HR column.  Four peaks 
are indicated. (C and F) SDS-PAGE analysis of the peaks shown in B and E. 
 
peak 1 was in the void volume, likely aggregated form of the DDX41 proteins and peaks 3 and 
4 were probably degraded fractions.  Thus, I collected the monomer fractions of both DDX41 
variants for the subsequent biochemical assays. 
 
4.8 R525H protein has reduced unwinding activity but retains normal 
strand annealing activity 
With the two purified proteins above, I wanted to check if DDX41 unwinds RNA:DNA hybrid, 
which mirrors the R-loop structure.  I performed the helicase assay of both WT and R525H 
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Figure 3. Purification of DDX41 proteins. (A and D) SDS-PAGE nalysis of the eluted DDX41-WT (A) and DDX41-R525H (D) 
fractions from a Ni-NTA column. M, marker. Eluted fractions 4-20 are shown. (B and E) Chromatographic profiles of recombinant 
DDX41-WT (B) and DDX41-R525H (E) proteins eluted from a Sephacryl S-300 HR column. Four peaks are indicated. (C and F) SDS-




mutant proteins.  Compared with the DDX41-WT, a significant decrease in the unwinding 
activity was observed in the mutant (Figure 20A), indicating the mutant reduced its  
 
 
Figure 20. Helicase and annealing activities of DDX41-WT and R525H mutant proteins 
on RNA: DNA hybrids.  (A) A representative image of helicase reactions performed by 
incubating 0.5 nM of 3’ tail 30-mer RNA and 45-mer complementary DNA hybrid substrate 
with increasing protein concentration (0.09, 0.18, 0.37, 0.75, 1.5, 3.0 μM) at 37 °C for 15 min.  
(B and C) Representative images of strand annealing assays performed by incubating 0.5 nM 
of P- labelled 30-mer RNA and 0.5 nM of unlabeled 45-mer complementary DNA with 
increasing protein concentration (0.09, 0.18, 0.37, 0.75, 1.5, 3.0 μM) at 37 °C for 15 min, 
without ATP (B) and with ATP (C).  DNA is represented with a black line and RNA with a grey 
line. NE, no enzyme; No cold, no unlabeled complementary strand; Filled triangle, heat-


































































helicase activity.  Further, I compared strand annealing activities of both WT and mutant, and 
no significant difference was found (Figure 20B).  Interestingly, when the same annealing assay 
reaction (shown in Figure B) was performed in the presence of ATP, WT unwound the 
RNA:DNA hybrid, whereas R525H failed to do so.  Hence, there were accumulated RNA:DNA 
hybrids in the mutant reactions (Figure 20C).  So, I found DDX41-WT efficiently performs 
both helicase and annealing activity whereas DDX41-R525H mutant has reduced helicase 
activity but retained annealing activity.  To elaborate, in the presence of ATP, R525H showed 
significantly high strand annealing when compared to WT; whereas, although WT exhibited 
annealing activity but simultaneously it unwound the RNA:DNA hybrid formed after the 
annealing process.  This led us to conclude that WT binds to the RNA:DNA hybrid structures 
in the R-loops and then resolves the structure for further DDR processing.  In summary, these 
data suggested that DDX41-WT resolves RNA:DNA hybrids, whereas R525H tends to 
accumulate it. 
 
4.9 DDX41 co-localizes with R-loops 
Since DDX41 negatively regulates R-loops formation, next, I wanted to investigate whether 
DDX41 directly interacts with R-loop structures, i.e., colocalizes with RNA:DNA hybrids.  
Here, I used RNase H again to specifically degrade RNA:DNA hybrids.  I treated WT (Figure 
21A) and DDX41-KO cells (Figure 21B) with Bm to observe S9.6-foci formation and 
colocalization in WT cells (if any) at 1 h.  Intriguingly, I found that DDX41 colocalized with 
R-loops/S9.6 in the absence of RNase H (Figure 21A and D), indicating its direct interaction 
with R-loops in the nucleus.  Moreover, the number of S9.6-foci was higher in KO cells (average 
10 foci/cell) than in WT cells (4 foci/cell) after 1 h of Bm treatment (Figure 21B and C).  There 
is prominent S9.6 signal in nucleoli and cytoplasm that presumably largely originates from 
ribosomal RNA (Smolka et al., 2021).  Strikingly, these results correspond with our in vitro 
(Figure 20) and dot blot data (Figure 18).  Therefore, I conclude that DDX41 colocalizes with 






Figure 21. DDX41 colocalizes with R-loops upon DNA insult.  Immunofluorescence staining 
of WT (A) and DDX41-KO (B) HT1080 cells at 1 h after Bm (30 μg/mL, 16 h) treatment, with 
and without RNase H treatment in three biological replicates.  (C) Quantitative analysis of the 
percentage colocalization of S9.6 and DDX41 shown in panel A.  (D) Quantitative analysis of 
S9.6 foci in WT and DDX41-KO HT1080 cells without or with Bm treatment (16 h post 30 
μg/mL).  The number of cells analyzed are 100 per channel.  Error bars indicate mean ± SD of 
cells per channel. UT, untreated; Bm, bleomycin. 
 
 
4.10 DDX41 colocalizes with transcriptional machinery 
Because R-loops are frequently formed during transcription (Belotserkovskii et al., 2018), I 







































































DDX41 colocalizes with the transcriptional machinery and if there is any difference in 
colocalization before and after DNA damage. There was no colocalization between DDX41 and 
RNA Pol II in the absence of DNA damage.  After the bleomycin treatment, around 70 % of 
DDX41 colocalized with RNA pol II at 1 h, furthermore, there was 1.5 times increase in RNA 
Pol II in HT1080 cells (Figure 22).  Possibly, upon the bleomycin treatment, RNA Pol II 
accumulated at the DSB sites due to halted passage at the lesion site, where DDX41 is recruited 
to resolve R-loops. 
Besides DDX41’s potential role in DSB-induced R-loops metabolism, I wanted to know 
whether transcription-replication collisions cause the increased DSBs in DDX41 
 
 
Figure 22. DDX41 colocalizes with RNA Pol II upon bleomycin treatment.  
Immunofluorescence staining of HT1080 cells after bleomycin (30 μg/mL, overnight) treatment 
in three biological replicates and quantitative analysis of percentage colocalization of RNA Pol 
II and DDX41 shown in panel A. The number of cells analyzed are 100 per channel.  Error bars 

















































depletion cells.  I have sent our WT and DDX41-KO cell lines to Dr. Peter Sterling’s lab at 
UBC, who will measure the transcription–replication collision events as PLA (Proximity 
Ligation Assay) signals between PCNA (Proliferating cell nuclear antigen, for replication) 
and RNA Pol II (transcription). 
 
4.11 Patient mutant R525H exhibits diminished DDR and increased 
DNA damage when  reconstituted in wildtype or DDX41 KO cells 
To explore the potential cellular pathogenesis of the R525H mutant, I overexpressed the 
DDX41-WT or DDX41-R525H genes in both WT and DDX41-KO HT1080 cell lines.  After 
Bm, UV, and HU treatment, I examined the relative abundance of the DDR-related proteins 
and R-loops status by Western and dot blotting respectively.  Like the Western blot results of 
DDX41-KO HT1080 cells (Figure 12), both WT and DDX41 KO backgrounds overexpressing 
the R525H mutant showed significantly higher γH2AX and 53BP1 levels along with delayed 
and diminished DNA repair levels, indicated by pBRCA1 protein level after Bm (Figure 23A), 
UV (Figure 23B) and HU (Figure 23C) treatment.  DSB, indicated by γH2AX and 53BP1 
levels, was resolved within 2-4 h after the DNA damage in WT overexpression cell lines, but it 
took 8-24 h in DDX41-R252H overexpressing cells, both in WT and DDX41 KO cell 
background.  Moreover, the phosphorylation of BRCA1 protein was earlier, around 1-2 h, in 
WT overexpressed cells than in DDX41-R525H overexpressed cells, i.e., around 4-8 h after the 
DNA damage. 
In addition, dot blot assays also showed that R525H had elevated and persistent 
RNA:DNA hybrid levels (until 4 h) when compared to WT (until 0.5-1 h) after Bm (Figure 
24A and 25A), UV (Figure 24B and 25B), or HU (Figure 24C and 25C) treatment in DDX41-
KO (Figure 24) and WT (Figure 25) cell background.  Thus, I concluded that the patient 
mutant R525H dysregulates DDR and DNA repair pathways, which may explain the 





Figure 23. Overexpression of the R525H mutant exhibits prolonged DNA damage and 
diminishes repair.  Western blot assays of some DDR proteins in DDX41-WT or DDX41- 
R525H overexpressed WT and DDX41-KO HT1080 cell lines after Bm (30 µg/mL for 16 h, A), 
UV (50 J/m2, B), and HU (10 mM, 16 h, C) at various time points (0.5, 1, 2, 4, 8, and 24 h) in 


























































































































































Figure 24. Overexpression of the R525H mutant perturbs RNA:DNA hybrids in DDX41- 
KO HT1080 cells.  Dot blot assay of HT1080 DDX41-KO cells and DDX41-KO cells expressing 
DDX41-WT or DDX41-R525H genes at different time points (UT, 0.25, 0.5, 1, 2, and 4 h) after 
Bm (30 μg/mL, 16 h, A), UV (50J/m2, B), and HU (10 mM, 16 h, C) treatments in three biological 
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Figure 25. Overexpression of the R525H mutant perturbs RNA:DNA hybrids in WT 
HT1080 cells.  Dot blot assay of HT1080 WT cells and WT cells expressing DDX41-WT or 
DDX41-R525H genes at different time points (UT, 0.25, 0.5, 1, 2, and 4 h) after Bm (30 μg/mL, 
16 h, A), UV (50J/m2, B), and HU (10 mM for 16 h, C) treatments in three biological replicates.  
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5  DISCUSSION 
5.1 DDX41 is an emerging DDR-associated protein 
DDX41 is well known for its role as a host intracellular DNA sensor against DNA virus 
infection (Zhang et al., 2011c).  Both germline and acquired somatic mutations of DDX41 
stimulate the development of MDS and AML (Abou Dalle et  al .,  2020; Cardoso et  al. ,  
2016; Ding et al . ,  2012; Hosono, 2019; Saygin and Godley, 2021) .  To investigate 
the possible mechanism involved in the pathogenesis of MDS/AML, extensive research has 
been taking place, and now the attention has been driven to DNA damage and alteration of the 
DDR, which are critical features of deregulation of genomic stability (Boehrer et al., 2009; 
Cavelier et al., 2009; Kefala et al., 2013; Popp et al., 2017; Satoh et al., 2012).  DEAD-box 
proteins, such as DDX1 (Li et al., 2008; Zhang et al., 2011a) and DDX3 (Sun et al., 2013; 
Szappanos et al., 2018), which have well-known functions in the innate immune response, are 
also intriguingly involved in DDR.  On the other hand, several DDR genes, such as ATM 
(Grosjean-Raillard et al., 2009), XPD and XRCC1 (Joshi et al., 2016),  BRCC (Meyer et al., 
2020), and HLTF (Takaoka et al., 2019) have been associated with MDS/AML.   
DEAD-box helicases are usually involved in RNA metabolism, such as mRNA splicing, 
translation initiation, ribosome biogenesis, and RNA degradation (Valentini and Linder, 2021); 
however, so far more than a dozen of DEAD-box helicases has been identified in DNA repair.  
They are DDX1 (Kim et al., 2020; Li et al., 2016a), DDX3 (Chan et al., 2019), DDX5 (Kim et 
al., 2020), DDX6 (Bergkessel and Reese, 2004), DDX11 (Abe et al., 2018; Guo et al., 2015; 
Shah et al., 2013), DDX17 (Adamson et al., 2012; Koo et al., 2015; Li et al., 2016b), DDX19 
(Hodroj et al., 2017), DDX21 (Kim et al., 2020), DDX23 (Sridhara et al., 2017), DDX47 
(Okamoto et al., 2019), DDX54 (Milek et al., 2017) , DDX56 (Kouyama et al., 2019), DDX58 
(Malachin et al., 2017; Ranoa et al., 2016), and DHX9 (Chakraborty et al., 2018b; Cristini et 
al., 2018; Kim et al., 2020).  To briefly mention, DDX5, also known as p68, localizes in DNA 
damage sites (Kahlina et al., 2004).  DHX9, also known as RNA helicase A, is associated 
directly with DNA repair marker γ-H2AX after actinomycin D treatment in HeLa cells (Mischo 
et al., 2011; Mischo et al., 2005).  DDX1 is found to facilitate the removal of RNA and 
homologous recombination at DSBs (Li et al., 2016a).  Biomedical and genetic approaches have 





The potential role of DDX41 in DDR is just emerging.  Recently, in a zebrafish model, a 
study revealed the importance of DDX41 in erythropoiesis regulation as deficiency and 
mutations in DDX41 exhibits ATM- and ATR-mediated cell arrest triggered by DNA damage, 
genomic stress, and misexpression and alternative splicing of genes related to cell cycle 
(Weinreb et al., 2020). My data provide evidence that DDX41 is another DEAD-box protein 
that functions in DDR: it assists DNA repair by resolving R-loop structures and precludes 
genome instability. 
 
5.2  DDX41 is required to facilitate DNA repair  
My work shows that with the loss of DDX41, the DNA damage measured by γ- H2AX and 
53BP1 levels becomes extensive and longer in duration; in addition, the DNA repair signalling 
(phosphorylation of BRCA1 tO pBRCA1) was diminished and occurred much later compared 
to wildtype cells.  The DNA damage-induced γ-H2AX foci formation is a critical and primary 
cellular response to DSB, and the number of γ-H2AX foci decreases as DSBs are repaired 
(Redon et al., 2009).  In our confocal imaging studies, γ-H2AX foci were resolved over the time 
course of 4 h after various types of DNA damage in wild type cells, whereas in DDX41 
knockout cells these foci persisted until 24 h.  DDX1 is recruited to the DNA damage sites, 
early at 30 min upon IR exposure and much later after 24 h of UV and cisplatin treatments, thus 
facilitating double strand break repair (Li et al., 2008).  An alkaline comet assay was performed 
to assess the lesions that particularly signifies DSB.  Intriguingly, the alkaline comet assays 
bolstered our Western blots and immunofluorescence results, i.e., the tail moment indicated by 
the damaged DNA migrated in the alkaline comet assay was longer in DDX41-KO (24 h) than 
WT cells (4 h). 
The DDR factor 53BP1 marks the DNA damage site after γ-H2AX recruitment and 
regulates the choice between HR and NHEJ DNA repair pathways (Bunting et al., 2010; 
Chapman et al., 2013).  Similarly, pBRCA1 chooses between HR and NHEJ repair pathways 
by deciding on various unified factors (Biehs et al., 2017).  Interestingly, when 53BP1 and 
pBRCA1 localize collectively on the damage site, they promote for HR-mediated repair.  Our 
Western blot results show the levels of 53BP1 and pBRCA1 largely mirrored each other, 




higher DNA damage and delayed DNA repair protein levels in DDX41-knockout cells reflect 
the importance of DDX41 in DSB repair. 
 
5.3 DDX41 resolves R-loops 
The novel function of DDX41 in relation to R-loop structures is just emerging. Using zebrafish, 
it was found excess R-loop structures formed in DDX41 mutant animals, which deterred the 
equilibrium of hemogenic endothelium, hematopoietic stem and progenitor cells required for 
cellular fitness (Weinreb et al., 2021).  Another research revealed DDX41 depletion leads to 
replication stress, DNA damage, inflammatory signaling and accumulation of R-loop structures, 
whereas this accumulation is opposed in the presence of DDX41 through unwinding RNA:DNA 
hybrids at gene promoter  (Mosler et al., 2021).  Correspondingly, our results showed that DDX41 
protein unwinds RNA:DNA hybrids in vitro, suggesting its function in removing and regulating R-
loops.  I also performed in vitro annealing assays using DDX41-WT and R525H mutant 
proteins and deciphered that both could anneal the RNA: DNA hybrids without any significant 
difference.  Excitingly, a significant difference was observed when this annealing assay was 
performed in the presence of ATP, whereas the DDX41 mutant showed accumulation of R-loop 
structures and WT was able to unwind the RNA:DNA hybrids.  Herein, I concluded that DDX41 
is required for resolving and regulating R-loops. 
Compelling evidence has implicated several other DEAD-box proteins in the suppressing 
co-transcriptional R-loop structures, including DDX19, DDX21, DDX23, and DDX47.  In 2017, 
DDX19 was discovered to utilize its helicase activity to resolve R-loops in vitro (Hodroj et al., 
2017).  In a similar study, the phosphorylation of DDX23 by a serine/arginine protein kinase 2 
(SRPK2) was found to initiate a signal transduction cascade to help DDX23 resolve R-loops 
(Sridhara et al., 2017).  Also, DDX21 was discovered to cooperate with SIRT7 to resolve R-loops 
and safeguard genome stability (Song et al., 2017).  In 2018, DDX47 was added to the list as it 
interacts with Fanconi anemia protein, FANCD2, during mild replication stress to decrease the 
number of R-loops by reducing transcription–replication collisions (Okamoto et al., 2019).  In 
2019, DDX21, together with H3K27me3 demethylase JMJD3, was shown to resolve aberrant R-
loops (Argaud et al., 2019).  In 2020, DDX5 was reported to promote homologous recombination 
repair by acting as an R-loop-resolvase at the sites of DSBs in U2OS- 265 and DRGFP cells (Yu 




in the same DEAD-box family?  One possibility is that various DEAD-box helicases act distinctly 
on R-loops based on (1) type of R-loop, (2) different genome sites, and 3) cell or tissue-specific.  
Nevertheless, further studies are required. 
 
5.4  DDX41: a potential co-transcriptional suppressor of transcription 
replication conflicts 
Transcription-replication collisions (TRCs), formed due to unresolved R-loop  structures, are 
another threat to genomic stability.  Many reports suggest that some well-identified DNA repair 
proteins like BRCA1 and FANCD2 function as R-loop resolvases at the TRC locations, but the 
mechanism is still not explored well (Bhatia et al., 2014; Domínguez-Sánchez et al., 2011; 
Schwab et al., 2015).  In my project, I anticipate that the absence of DDX41 (or in the presence 
of R525H mutant) might result in higher TRCs due to R-loop accumulation in the cells.  
Studies in this field have revealed the R-loop resolving helicase, Senataxin, moves along with 
the replication fork to promote the progression through RNA polymerase II transcribed genes 
(Alzu et al., 2012; Mischo et al., 2011; Skourti-Stathaki et al., 2011).  Also,  the  DEAD-box 
hel icase  DDX39B is implicated in inhibiting R-loop accumulation during transcription and 
suppressing transcription-replication conflicts upon DNA damage (Pérez-Calero et al., 2020).  
To date, I have found the colocalization of DDX41 and RNA polymerase II, suggesting 
DDX41 might interact with the transcription machinery to help it release from the DSB-prone 
sites and maintain the genome integrity from pathological R-loop accumulation.  Further, 
ongoing proximal ligation assays (PLA) will give me direct evidence, measuring the collision 
events between replication and transcriptional machinery, i.e., PCNA and RNA Pol II, 
respectively, in WT and DDX41 KO cells after DNA insult. 
 
5.5  Prospective molecular pathogenesis of MDS and AML R525H mutation  
My study suggests that in the absence of DDX41, cells display elevated DSBs and delayed and 
diminished pBRCA1 activation.  My work also identifies that DDX41 is a pivotal R-loop 
resolvase that facilitates the repair of DSBs.  By performing dot blots after different DNA 
damage, I observed increased and accumulated R-loop structures in DDX41-R525H mutated 




my findings, another DEAD-box helicase, DDX5, is overexpressed in acute myeloid leukemia, 
counteracting DSB-related DNA deletions and repair defects by resolving persistent R-loops 
(Yu et al., 2020).  My working model (Figure 26) supplements the exciting possibility of  
 
Figure 26.  A proposed model of the role of DDX41 in co-transcriptional resolution of R-
loops to maintain genome stability.  RNAP, RNA polymerase; DSB, Double-strand breaks; 
WT, Wildtype; CSB, Cockayne syndrome protein B. Modified from (Hamperl and Cimprich, 
2014; Hegazy et al., 2020). 
 
DEAD-box helicases associated with R-loop and other aberrant structures.  The model 
illustrates that DDX41-WT co-transcriptionally resolves any unwanted R-loop structure during 
transcription (Figure 26, left), whereas DDX41-R525H mutant fails to do that, hence, accumulates 
R-loops. The accumulation of R-loops results in transcription-replication collisions, DSBs, 
genome instability, and possibly MDS and AML. Similarly, another DEAD-box helicase, 
DDX39B, was recently determined to co-transcriptionally remove the pathological R-loop 
structures as its overexpression leads to hybrid suppression and restraining of the R-loop 




as a consequence of DNA damage (from any source) in the cells, and there is a tendency of R-
loop accumulation at the site (Cristini et al., 2019).  DDX41-WT and other DNA repair proteins 
like RAD52 and CSB resolve R-loops, whereas DDX41-R525H mutant fails, resulting in 
delayed DNA repair and possible MDS/AML.  Correspondingly, DDX21 collaborates with 
SIRT7 to check any R-loop formation and maintain genome integrity (Song et al., 2017).  
Describing the collaboration above, both SIRT7 and DDX21 are related to Pol I and Pol II. In 
the wild type cells, DDX21-related hypoacetylation/deacetylation which is needed for 
unwinding of co-transcriptional R loops is maintained, where SIRT7-KO cells results in 
impaired helicase activity due to hyperacetylation of DDX21, resulting in stalled activity of Pol 
I and Pol II, R loop accumulation, and eventually DNA damage.  Many other DEAD-box 
helicases such as DHX9, DDX5, DDX1, and DDX21 interact with ATAD5, a PCNA unloader, 
to diminish RNA:DNA hybrids under both standard and replication stress conditions (Kim et al., 
2020). 
It is exciting to apply this model of DDX41 to the pathogenesis of MDS and AML; however, 
additional pathways and clinical studies on how these pathways interplay and influence each 
other should be investigated to make the pathogenesis effect evident.  Our work opens a window 
that illustrates how DDX41 associated regulation of DNA damage response pathway and R-
loop formation are interlinked and possibly applicable to MDS and AML pathologies and other 
diseases. 
 
6  CONCLUSIONS AND FUTURE WORK 
6.1 Conclusions 
DDX41 mutations are associated with hematologic malignancies, including MDS and AML; 
however, the molecular pathogenesis is unknown.  Since dysfunction of DNA damage and 
repair is one of the molecular pathogenesis of MDS and AML, I explored the potential role of 
DDX41 in DNA repair.  Using HT1080 and HeLa DDX41 KO cell lines, I found DDX41-
depelition leads to increased DNA damage, indicated by increased and prolonged DNA double 
strand breaks and increased comet tail formation.  Further, I found there were increased R-
loops in DDX41 KO cells after DNA insult.  DDX41 protein resolves R-loops in vitro, but the 




localized with DSB marker γ-H2AX and R-loop marker S9.6.  When overexpressed in DDX41 
KO or wildtype cell lines, R525H-expressing cells had significantly more R-loops than WT-
expressing cells.  Taken together, my results suggest DDX41 utilizes its unwinding activities to 
resolve R-loops at the DSB sites, which is critically important for DSB repair and genome 
stability, and dysregulation of this pathway might lead to MDS/AML. 
Even though if the confocal microscope is perfectly tuned it is not adequate to ascertain 
whether two proteins tagged with fluorescent molecules are colocalizing. Therefore, more 
specific techniques like pull down assay and proximity ligation assay must be used for future 
studies that readily discriminate over specific antibodies or probes targeting different proteins. 
 
6.2 Future work 
To confirm the correlation of DNA damage and DDR with DDX41, I will investigate the 
colocalization of DDX41 with 53BP1, another DSB marker, since both γ-H2AX and 53BP1 can 
be visualized as foci at the sites of DSB by confocal microscopy (Rothkamm et al., 2015).  
Further, our Western blots and dot blots showed there were elevated γ-H2AX and R-loop levels 
in R525H-expressed cell lines; additional immunofluorescence experiments will yield perceptive 
information about whether R525H mutation has a direct localization defect.  Hence, the 
colocalization of GFP-tagged DDX41-WT and GFP-tagged DDX41-R525H with DSB marker 
γH2AX/53BP1 could be examined and compared to produce further details on whether and how 
mutations in DDX41 alter the DDR pathway, particularly the initial steps of DNA damage 
responses. 
  Although various experiments led us to conclude the importance of DDX41 in DSB 
repair by resolving R-loops, whether DDX41 assists in the HR repair pathway remains unknown.  
To address this, I-SceI endonuclease that generates a DSB in the cassette of the dysfunctional 
GFP gene fragment in DR-GFP U2OS cell line (Gunn and Stark, 2012) can be used to compare 
HR efficiency in WT and siRNA DDX41 knockdown cell lines.  This DSB formed by I-SceI can 
be repaired via HR and the downstream GFP can be used as the readout to measure HR efficacy.  
Lastly, the investigation of transcription and replication collisions (TRCs) status in WT vs. 
DDX41-KO cell lines, DDX41-WT vs. DDX41-R525H-expressed cell lines using proximity 
ligation assay (collaborating with Dr. Peter Stirling at UBC) could also be informative to 




7.  REFERENCES 
 
Abe, T., Ooka, M., Kawasumi, R., Miyata, K., Takata, M., Hirota, K., and Branzei, D. (2018). 
Warsaw breakage syndrome DDX11 helicase acts jointly with RAD17 in the repair of bulky 
lesions and replication through abasic sites. Proc Natl Acad Sci U S A. 115, 8412-8417. 
 
Abou Dalle, I., Kantarjian, H., Bannon, S.A., Kanagal-Shamanna, R., Routbort, M., Patel, K.P., 
Hu, S., Bhalla, K., Garcia-Manero, G., and DiNardo, C.D. (2020). Successful lenalidomide 
treatment in high risk myelodysplastic syndrome with germline DDX41 mutation. Am. J. 
Hematol. 95, 227-229. 
 
Adamson, B., Smogorzewska, A., Sigoillot, F.D., King, R.W., and Elledge, S.J. (2012). A 
genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as 
a component of the DNA-damage response. Nat. Cell Biol. 14, 318-328. 
 
Agafonov, D.E., Deckert, J., Wolf, E., Odenwälder, P., Bessonov, S., Will, C.L., Urlaub, H., and 
Lührmann, R. (2011). Semiquantitative proteomic analysis of the human spliceosome via a novel 
two-dimensional gel electrophoresis method. Mol. Cell. Biol. 31, 2667-2682. 
 
Aguilera, A., and García-Muse, T. (2012). R loops: from transcription byproducts to threats to 
genome stability. Mol. Cell 46, 115-124. 
 
Almeida, A.M., and Ramos, F. (2016). Acute myeloid leukemia in the older adults. Leuk. Res. 
Rep. 6, 1-7. 
 
Alzu, A., Bermejo, R., Begnis, M., Lucca, C., Piccini, D., Carotenuto, W., Saponaro, M., 
Brambati, A., Cocito, A., and Foiani, M. (2012). Senataxin associates with replication forks to 
protect fork integrity across RNA-polymerase-II-transcribed genes. Cell 151, 835-846. 
 
Anderson, J.S.J., and Parker, R. (1998). The 3′ to 5′ degradation of yeast mRNAs is a general 
mechanism for mRNA turnover that requires the SKI2 DEVH box protein and 3′ to 5′ 
exonucleases of the exosome complex. EMBO J. 17, 1497-1506. 
 
Argaud, D., Boulanger, M.-C., Chignon, A., Mkannez, G., and Mathieu, P. (2019). Enhancer-
mediated enrichment of interacting JMJD3–DDX21 to ENPP2 locus prevents R-loop formation 
and promotes transcription. Nucleic Acids Res. 47, 8424-8438. 
 
Auboeuf, D., Hönig, A., Berget, S.M., and O'Malley, B.W. (2002). Coordinate regulation of 
transcription and splicing by steroid receptor coregulators. Science 298, 416-419. 
 
Ball, H.L., Myers, J.S., and Cortez, D. (2005). ATRIP binding to replication protein A-single-
stranded DNA promotes ATR–ATRIP localization but is dispensable for Chk1 phosphorylation. 
Mol. Biol. Cell. 16, 2372-2381. 
 
Basu, U., Meng, F.-L., Keim, C., Grinstein, V., Pefanis, E., Eccleston, J., Zhang, T., Myers, D., 




deaminase to both strands of transcribed duplex DNA substrates. Cell 144, 353-363. 
 
Bejar, R., Stevenson, K., Abdel-Wahab, O., Galili, N., Nilsson, B., Garcia-Manero, G., 
Kantarjian, H., Raza, A., Levine, R.L., and Neuberg, D. (2011). Clinical effect of point mutations 
in myelodysplastic syndromes. NEJM. 364, 2496-2506. 
 
Belotserkovskii, B.P., Tornaletti, S., D’Souza, A.D., and Hanawalt, P.C. (2018). R-loop 
generation during transcription: Formation, processing and cellular outcomes. DNA Repair 71, 
69-81. 
 
Bergkessel, M., and Reese, J.C. (2004). An Essential Role for the Saccharomyces cerevisiae 
DEAD-Box Helicase DHH1 in G1/S DNA-Damage Checkpoint Recovery. Genetics 167, 21-33. 
 
Bernstein, K.A., Gangloff, S., and Rothstein, R. (2010). The RecQ DNA helicases in DNA 
repair. Annu. Rev. Genet. 44, 393-417. 
 
Bessonov, S., Anokhina, M., Will, C.L., Urlaub, H., and Lührmann, R. (2008). Isolation of an 
active step I spliceosome and composition of its RNP core. Nature 452, 846-850. 
 
Bhatia, V., Barroso, S.I., García-Rubio, M.L., Tumini, E., Herrera-Moyano, E., and Aguilera, A. 
(2014). BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor 
PCID2. Nature 511, 362-365. 
 
Biehs, R., Steinlage, M., Barton, O., Juhász, S., Künzel, J., Spies, J., Shibata, A., Jeggo, P.A., 
and Löbrich, M. (2017). DNA double-strand break resection occurs during non-homologous end 
joining in G1 but is distinct from resection during homologous recombination. Mol. Cell 65, 
671-684. e675. 
 
Boehrer, S., Ades, L., Tajeddine, N., Hofmann, W., Kriener, S., Bug, G., Ottmann, O., Ruthardt, 
M., Galluzzi, L., and Fouassier, C. (2009). Suppression of the DNA damage response in acute 
myeloid leukemia versus myelodysplastic syndrome. Oncogene 28, 2205-2218. 
 
Bradford, M., (1976). A rapid and sensitive method for the quantitation of microgram quantities 
of protein utilizing the principle of protein-dye binding. Anal Biochem 72. 248–254 
 
Brosh Jr, R.M., and Bohr, V.A. (2007). Human premature aging, DNA repair and RecQ 
helicases. Nucleic Acids Res. 35, 7527-7544. 
 
Bunting, S.F., Callén, E., Wong, N., Chen, H.-T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, 
N., Fernandez-Capetillo, O., and Cao, L. (2010). 53BP1 inhibits homologous recombination in 
Brca1-deficient cells by blocking resection of DNA breaks. Cell 141, 243-254. 
 
Byrd, A.K., and Raney, K.D. (2012). Superfamily 2 helicases. Front. Biosci. 17, 2070. 
 
Cannan, W.J., and Pederson, D.S. (2016). Mechanisms and consequences of double‐strand DNA 




Cardoso, S.R., Ryan, G., Walne, A.J., Ellison, A., Lowe, R., Tummala, H., Rio-Machin, A., 
Collopy, L., Al Seraihi, A., and Wallis, Y. (2016). Germline heterozygous DDX41 variants in a 
subset of familial myelodysplasia and acute myeloid leukemia. Leukemia 30, 2083-2086. 
 
Caruthers, J.M., and McKay, D.B. (2002). Helicase structure and mechanism. Curr. Opin. Struct. 
Biol. 12, 123-133. 
 
Cavelier, C., Didier, C., Prade, N., Mansat-De Mas, V., Manenti, S., Recher, C., Demur, C., and 
Ducommun, B. (2009). Constitutive activation of the DNA damage signaling pathway in acute 
myeloid leukemia with complex karyotype: potential importance for checkpoint targeting 
therapy. Cancer Res. 69, 8652-8661. 
 
Cerritelli, S. M., and Crouch, R. J. (2009). Ribonuclease H: the enzymes in eukaryotes. FEBS J 
276(6), 1494-1505. 
 
Chakraborty, P., Huang, J.T., and Hiom, K. (2018a). DHX9 helicase promotes R-loop formation 
in cells with impaired RNA splicing. Nat. Commun. 9, 1-14. 
 
Chan, C.H., Chen, C.M., Lee, Y.W., and You, L.R. (2019). DNA Damage, Liver Injury, and 
Tumorigenesis: Consequences of DDX3X Loss. Mol. Cancer Res. 17, 555-566. 
 
Chapman, J.R., Barral, P., Vannier, J.-B., Borel, V., Steger, M., Tomas-Loba, A., Sartori, A.A., 
Adams, I.R., Batista, F.D., and Boulton, S.J. (2013). RIF1 is essential for 53BP1-dependent 
nonhomologous end joining and suppression of DNA double-strand break resection. Mol. Cell 
49, 858-871. 
 
Chatterjee, N., and Walker, G.C. (2017). Mechanisms of DNA damage, repair, and mutagenesis. 
Environ. Mol. Mutagen 58, 235-263. 
 
Chen, J., Ghorai, M.K., Kenney, G., and Stubbe, J. (2008). Mechanistic studies on bleomycin-
mediated DNA damage: multiple binding modes can result in double-stranded DNA cleavage. 
Nucleic Acids Res. 36, 3781-3790. 
 
Chen, L., Chen, J.-Y., Huang, Y.-J., Gu, Y., Qiu, J., Qian, H., Shao, C., Zhang, X., Hu, J., and 
Li, H. (2018). The augmented R-loop is a unifying mechanism for myelodysplastic syndromes 
induced by high-risk splicing factor mutations. Mol. Cell 69, 412-425. e416. 
 
Chuang, R.-Y., Weaver, P.L., Liu, Z., and Chang, T.-H. (1997). Requirement of the DEAD-Box 
protein ded1p for messenger RNA translation. Science 275, 1468-1471. 
 
Ciccia, A., and Elledge, S.J. (2010). The DNA damage response: making it safe to play with 
knives. Mol. Cell 40, 179-204. 
 
Cristini, A., Groh, M., Kristiansen, M.S., and Gromak, N. (2018). RNA/DNA Hybrid 
Interactome Identifies DXH9 as a Molecular Player in Transcriptional Termination and R-Loop-




Cristini, A., Ricci, G., Britton, S., Salimbeni, S., Huang, S.-y.N., Marinello, J., Calsou, P., 
Pommier, Y., Favre, G., and Capranico, G. (2019). Dual processing of R-Loops and 
topoisomerase I induces transcription-dependent DNA double-strand breaks. Cell Rep. 28, 3167-
3181. e3166. 
 
Dillingham, M.S. (2011). Superfamily I helicases as modular components of DNA-processing 
machines. Biochem. Soc. Trans. 39, 413-423. 
 
Ding, L., Ley, T.J., Larson, D.E., Miller, C.A., Koboldt, D.C., Welch, J.S., Ritchey, J.K., Young, 
M.A., Lamprecht, T., and McLellan, M.D. (2012). Clonal evolution in relapsed acute myeloid 
leukaemia revealed by whole-genome sequencing. Nature 481, 506-510. 
 
Domínguez-Sánchez, M.S., Barroso, S., Gómez-González, B., Luna, R., and Aguilera, A. 
(2011). Genome instability and transcription elongation impairment in human cells depleted of 
THO/TREX. PLoS Genet. 7, e1002386. 
 
Duployez, N., Marceau-Renaut, A., Boissel, N., Petit, A., Bucci, M., Geffroy, S., Lapillonne, H., 
Renneville, A., Ragu, C., and Figeac, M. (2016). Comprehensive mutational profiling of core 
binding factor acute myeloid leukemia. Blood. 127, 2451-2459. 
 
Dutta, D., Shatalin, K., Epshtein, V., Gottesman, M. E., & Nudler, E. (2011). Linking RNA 
polymerase backtracking to genome instability in E. coli. Cell 146(4), 533-543. 
 
Fenwarth, L., Caulier, A., Lachaier, E., Goursaud, L., Marceau-Renaut, A., Fournier, E., Lebon, 
D., Boyer, T., Berthon, C., and Marolleau, J.-P. (2021). Hereditary Predisposition to Acute 
Myeloid Leukemia in Older Adults. HemaSphere 5, e552. 
 
Fuller-Pace, F.V. (2013). DEAD box RNA helicase functions in cancer. RNA Biol. 10, 121-132. 
 
Gaillard, H., García-Muse, T., and Aguilera, A. (2015). Replication stress and cancer. Nat. Rev. 
Cancer 15, 276-289. 
 
García-Rubio, M., Aguilera, P., Lafuente-Barquero, J., Ruiz, J.F., Simon, M.-N., Geli, V., 
Rondón, A.G., and Aguilera, A. (2018). Yra1-bound RNA–DNA hybrids cause orientation-
independent transcription–replication collisions and telomere instability. Genes Dev. 32, 965-
977. 
 
Gatfield, D., Le Hir, H., Schmitt, C., Braun, I.C., Köcher, T., Wilm, M., and Izaurralde, E. 
(2001). The DExH/D box protein HEL/UAP56 is essential for mRNA nuclear export in 
Drosophila. Curr. Biol. 11, 1716-1721. 
 
Ginno, P.A., Lott, P.L., Christensen, H.C., Korf, I., and Chédin, F. (2012). R-loop formation is 
a distinctive characteristic of unmethylated human CpG island promoters. Mol. Cell 45, 814-
825. 
 




structure-function relationships. Curr. Opin. Struct. 3, 419-429. 
 
Grosjean-Raillard, J., Tailler, M., Ades, L., Perfettini, J., Fabre, C., Braun, T., De Botton, S., 
Fenaux, P., and Kroemer, G. (2009). ATM mediates constitutive NF-κB activation in high-risk 
myelodysplastic syndrome and acute myeloid leukemia. Oncogene 28, 1099-1109. 
 
Gunn, A., and Stark, J.M. (2012). I-SceI-based assays to examine distinct repair outcomes of 
mammalian chromosomal double strand breaks. Methods Mol. Biol. 920, 379-391. 
 
Guo, M., Hundseth, K., Ding, H., Vidhyasagar, V., Inoue, A., Nguyen, C.H., Zain, R., Lee, J.S., 
and Wu, Y. (2015). A Distinct Triplex DNA Unwinding Activity of ChlR1 Helicase. J. Biol. 
Chem. 290, 5174-5189. 
 
Haeusler, A.R., Donnelly, C.J., Periz, G., Simko, E.A., Shaw, P.G., Kim, M.-S., Maragakis, N.J., 
Troncoso, J.C., Pandey, A., and Sattler, R. (2014). C9orf72 nucleotide repeat structures initiate 
molecular cascades of disease. Nature 507, 195-200. 
 
Haferlach, C., Dicker, F., Herholz, H., Schnittger, S., Kern, W., and Haferlach, T. (2008). 
Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex 
aberrant karyotype. Leukemia 22, 1539-1541. 
 
Halazonetis, T.D., Gorgoulis, V.G., and Bartek, J. (2008). An Oncogene -induced DNA damage 
model for cancer development. Science 319, 1352-1355. 
 
Hamperl, S., and Cimprich, K.A. (2014). The contribution of co-transcriptional RNA: DNA 
hybrid structures to DNA damage and genome instability. DNA Repair 19, 84-94. 
 
Hegazy, Y.A., Fernando, C.M., and Tran, E.J. (2020). The balancing act of R-loop biology: The 
good, the bad, and the ugly. J. Biol. Chem. 295, 905-913. 
 
Hodroj, D., Recolin, B., Serhal, K., Martinez, S., Tsanov, N., Abou Merhi, R., and Maiorano, D. 
(2017). An ATR-dependent function for the Ddx19 RNA helicase in nuclear R-loop metabolism. 
EMBO J. 36, 1182-1198. 
 
Hoeijmakers, J.H. (2001). Genome maintenance mechanisms for preventing cancer. Nature 411, 
366-374. 
 
Horibe, S., Takagi, M., Unno, J., Nagasawa, M., Morio, T., Arai, A., Miura, O., Ohta, M., 
Kitagawa, M., and Mizutani, S. (2007). DNA damage check points prevent leukemic 
transformation in myelodysplastic syndrome. Leukemia 21, 2195-2198. 
 
Hosono, N. (2019). Genetic defects of chromosome 5q and 7q in myeloid neoplasms. Rinsho 
ketsueki. 60, 800-809. 
 
Iacobucci, I., Wen, J., Meggendorfer, M., Choi, J.K., Shi, L., Pounds, S.B., Carmichael, C.L., 




targeting of acute erythroleukemia. Nat. Genet. 51, 694-704. 
 
Ishikawa, H., and Barber, G.N. (2008). STING is an endoplasmic reticulum adaptor that 
facilitates innate immune signalling. Nature 455, 674-678. 
 
Jackson, R.N., Lavin, M., Carter, J., and Wiedenheft, B. (2014). Fitting CRISPR-associated Cas3 
into the helicase family tree. Curr. Opin. Struct. 24, 106-114. 
 
Jahn, A., Rane, G., Paszkowski-Rogacz, M., Sayols, S., Bluhm, A., Han, C.-T., Draškovič, I., 
Londoño, A., Kumar, A.P., and Buchholz, F. (2018). ZBTB48 is both a vertebrate telomere-
binding protein and a transcriptional activator. EMBO Rep. 18, 929-946. 
 
Jankowsky, E. (2011). RNA helicases at work: binding and rearranging. Trends Biochem. Sci. 
36, 19-29. 
 
Jiang, Y., Dunbar, A., Gondek, L.P., Mohan, S., Rataul, M., O'Keefe, C., Sekeres, M., 
Saunthararajah, Y., and Maciejewski, J.P. (2009). Aberrant DNA methylation is a dominant 
mechanism in MDS progression to AML. Blood 113, 1315-1325. 
 
Jiang, Y., Zhu, Y., Liu, Z.J., and Ouyang, S. (2017). The emerging roles of the DDX41 protein 
in immunity and diseases. Protein Cell 8, 83-89. 
 
Jiricny, J. (2006). The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell. Biol 7, 335-
346. 
 
Joshi, D., Korgaonkar, S., Shanmukhaiah, C., and Vundinti, B.R. (2016). Association of XPD 
(Lys751Gln) and XRCC1 (Arg280His) gene polymorphisms in myelodysplastic syndrome. Ann. 
Hematol. 95, 79-85. 
 
Jurica, M.S., Licklider, L.J., Gygi, S.P., Grigorieff, N., and Moore, M.J. (2002). Purification and 
characterization of native spliceosomes suitable for three-dimensional structural analysis. RNA 
8, 426-439. 
 
Kabeche, L., Nguyen, H.D., Buisson, R., and Zou, L. (2018). A mitosis-specific and R loop–
driven ATR pathway promotes faithful chromosome segregation. Science 359, 108-114. 
Kadono, M., Kanai, A., Nagamachi, A., Shinriki, S., Kawata, J., Iwato, K., Kyo, T., Oshima, K., 
Yokoyama, A., and Kawamura, T. (2016). Biological implications of somatic DDX41 p. R525H 
mutation in acute myeloid leukemia. Exp. Hematol. 44, 745-754. e744. 
 
Kahlina, K., Goren, I., Pfeilschifter, J., and Frank, S. (2004). p68 DEAD box RNA helicase 
expression in keratinocytes. Regulation, nucleolar localization, and functional connection to 
proliferation and vascular endothelial growth factor gene expression. J. Biol. Chem. 279, 44872-
44882. 
 
Kato, R., Miyagawa, K., and Yasuhara, T. (2019). The role of R-loops in transcription-associated 




Kefala, M., Papageorgiou, S.G., Kontos, C.K., Economopoulou, P., Tsanas, A., Pappa, V., 
Panayiotides, I.G., Gorgoulis, V.G., Patsouris, E., and Foukas, P.G. (2013). Increased expression 
of phosphorylated NBS1, a key molecule of the DNA damage response machinery, is an adverse 
prognostic factor in patients with de novo myelodysplastic syndromes. Leukemia Res. 37, 1576-
1582. 
 
Kemp, M.G., and Sancar, A. (2012). DNA excision repair: where do all the dimers go? Cell 
Cycle 11, 2997-3002. 
 
Kim, N., and Jinks-Robertson, S. (2012). Transcription as a source of genome instability. Nat. 
Rev. Genet. 13, 204-214. 
 
Kim, S., Kang, N., Park, S.H., Wells, J., Hwang, T., Ryu, E., Kim, B.G., Hwang, S., Kim, S.J., 
Kang, S., et al. (2020). ATAD5 restricts R-loop formation through PCNA unloading and RNA 
helicase maintenance at the replication fork. Nucleic Acids Res. 48, 7218-7238. 
 
Koo, C.X.e., Kobiyama, K., Shen, Y.J., LeBert, N., Ahmad, S., Khatoo, M., Aoshi, T., Gasser, 
S., and Ishii, K.J. (2015). RNA polymerase III regulates cytosolic RNA: DNA hybrids and 
intracellular microRNA expression. J. Biol. Chem. 290, 7463-7473. 
 
Kouyama, Y., Masuda, T., Fujii, A., Ogawa, Y., Sato, K., Tobo, T., Wakiyama, H., Yoshikawa, 
Y., Noda, M., and Tsuruda, Y. (2019). Oncogenic splicing abnormalities induced by DEAD‐Box 
Helicase 56 amplification in colorectal cancer. Cancer Sci. 110, 3132-3144. 
 
Lang, K.S., Hall, A.N., Merrikh, C.N., Ragheb, M., Tabakh, H., Pollock, A.J., Woodward, J.J., 
Dreifus, J.E., and Merrikh, H. (2017). Replication-transcription conflicts generate R-loops that 
orchestrate bacterial stress survival and pathogenesis. Cell 170, 787-799. 
 
Lasko, P. (2013). The DEAD-box helicase Vasa: evidence for a multiplicity of functions in RNA 
processes and developmental biology. Biochim Biophys Acta Gene Regul. Mech. 1829, 810-
816. 
 
Lee, K.-G., Kim, S.S.-Y., Kui, L., Voon, D.C.-C., Mauduit, M., Bist, P., Bi, X., Pereira, N.A., 
Liu, C., and Sukumaran, B. (2015a). Bruton’s tyrosine kinase phosphorylates DDX41 and 
activates its binding of dsDNA and STING to initiate type 1 interferon response. Cell Rep. 10, 
1055-1065. 
 
Lewinsohn, M., Brown, A.L., Weinel, L.M., Phung, C., Rafidi, G., Lee, M.K., Schreiber, A.W., 
Feng, J., Babic, M., and Chong, C.-E. (2016). Novel germ line DDX41 mutations define families 
with a lower age of MDS AND AML onset and lymphoid malignancies. Blood 127, 1017-1023. 
 
Li, L., Germain, D.R., Poon, H.Y., Hildebrandt, M.R., Monckton, E.A., McDonald, D., Hendzel, 
M.J., and Godbout, R. (2016). DEAD Box 1 Facilitates Removal of RNA and Homologous 
Recombination at DNA Double-Strand Breaks. Mol. Cell Biol. 36, 2794-2810. 
 




breaks. Mol. Cell Biol. 28, 6413-6425. 
 
Li, R., Sobreira, N., Witmer, P.D., Pratz, K.W., and Braunstein, E.M. (2016). Two novel 
germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia. 
Haematologica 101, e228. 
 
Lindahl, T., and Wood, R.D. (1999). Quality control by DNA repair. Science 286, 1897-1905. 
 
Linder, P. (2006). Dead-box proteins: a family affair—active and passive players in RNP-
remodeling. Nucleic Acids Res. 34, 4168-4180. 
 
Linder, P., and Fuller-Pace, F.V. (2013). Looking back on the birth of DEAD-box RNA 
helicases. Biochim Biophys Acta Gene Regul. Mech. 1829, 750-755. 
 
Liu, H.-Y., Nefsky, B.S., and Walworth, N.C. (2002). The Ded1 DEAD box helicase interacts 
with Chk1 and Cdc2. J. Biol. Chem. 277, 2637-2643. 
 
Lohman, T.M., Tomko, E.J., and Wu, C.G. (2008). Non-hexameric DNA helicases and 
translocases: mechanisms and regulation. Nat Rev Mol Cell Biol. 9, 391-401. 
 
Loomis, E.W., Sanz, L.A., Chédin, F., and Hagerman, P.J. (2014). Transcription-associated R-
loop formation across the human FMR1 CGG-repeat region. PLoS Genet. 10, e1004294. 
 
Lu, W.-T., Hawley, B.R., Skalka, G.L., Baldock, R.A., Smith, E.M., Bader, A.S., Malewicz, M., 
Watts, F.Z., Wilczynska, A., and Bushell, M. (2018). Drosha drives the formation of DNA: RNA 
hybrids around DNA break sites to facilitate DNA repair. Nat. Commun. 9, 1-13. 
 
Maciejewski, J.P., Padgett, R.A., Brown, A.L., and Müller-Tidow, C. (2017). DDX41-related 
myeloid neoplasia. Semin. Hematol., 54, 94-97. 
 
Magnusdottir, A., Johansson, I., Dahlgren, L.-G., Nordlund, P., and Berglund, H. (2009). 
Enabling IMAC purification of low abundance recombinant proteins from E. coli lysates. Nat. 
Methods 6, 477-478. 
 
Malachin, G., Reiten, M.R., Salvesen, Ø., Aanes, H., Kamstra, J.H., Skovgaard, K., Heegaard, 
P.M., Ersdal, C., Espenes, A., and Tranulis, M.A. (2017). Loss of prion protein induces a primed 
state of type I interferon-responsive genes. PLoS One 12, e0179881. 
 
Maréchal, A., and Zou, L. (2013). DNA damage sensing by the ATM and ATR kinases. Cold 
Spring Harb. Perspect. Biol. 5, a012716. 
 
Meyer, T., Jahn, N., Lindner, S., Röhner, L., Dolnik, A., Weber, D., Scheffold, A., Köpff, S., 
Paschka, P., and Gaidzik, V.I. (2020). Functional characterization of BRCC3 mutations in acute 
myeloid leukemia with t (8; 21)(q22; q22. 1). Leukemia 34, 404-415. 
 




M., Heyd, F., Ohler, U., et al. (2017). DDX54 regulates transcriptome dynamics during DNA 
damage response. Genome Res. 27, 1344-1359. 
 
Mischo, H.E., Gómez-González, B., Grzechnik, P., Rondón, A.G., Wei, W., Steinmetz, L., 
Aguilera, A., and Proudfoot, N.J. (2011). Yeast Sen1 helicase protects the genome from 
transcription-associated instability. Mol. Cell 41, 21-32. 
 
Mischo, H.E., Hemmerich, P., Grosse, F., and Zhang, S. (2005). Actinomycin D induces histone 
gamma-H2AX foci and complex formation of gamma-H2AX with Ku70 and nuclear DNA 
helicase II. J. Biol. Chem. 280, 9586-9594. 
 
Missel, A., Souza, A.E., Nörskau, G., and Göringer, H. (1997). Disruption of a gene encoding a 
novel mitochondrial DEAD-box protein in Trypanosoma brucei affects edited mRNAs. Mol. 
Cell Biol. 17, 4895-4903. 
 
Mosler, T., Conte, F., Mikicic, I., Kreim, N., Möckel, M., Flach, J., Luke, B., and Beli, P. (2021). 
R-loop proximity proteomics identifies a role of DDX41 in transcription-associated genomic 
instability. Nat. Portfolio. doi:10.21203/rs.3.rs-337351/v1. 
 
Mossner, M., Jann, J.-C., Wittig, J., Nolte, F., Fey, S., Nowak, V., Obländer, J., Pressler, J., 
Palme, I., and Xanthopoulos, C. (2016). Mutational hierarchies in myelodysplastic syndromes 
dynamically adapt and evolve upon therapy response and failure. Blood 128, 1246-1259. 
 
Namiki, Y., and Zou, L. (2006). ATRIP associates with replication protein A-coated ssDNA 
through multiple interactions. Proc. Natl. Acad. Sci. U.S.A. 103, 580-585. 
 
Ohle, C., Tesorero, R., Schermann, G., Dobrev, N., Sinning, I., and Fischer, T. (2016). Transient 
RNA-DNA hybrids are required for efficient double-strand break repair. Cell 167, 1001-1013. 
e1007. 
 
Okamoto, Y., Abe, M., Itaya, A., Tomida, J., Ishiai, M., Takaori-Kondo, A., Taoka, M., Isobe, 
T., and Takata, M. (2019). FANCD2 protects genome stability by recruiting RNA processing 
enzymes to resolve R-loops during mild replication stress. FEBS J. 286, 139-150. 
 
Omura, H., Oikawa, D., Nakane, T., Kato, M., Ishii, R., Ishitani, R., Tokunaga, F., and Nureki, 
O. (2016). Structural and Functional Analysis of DDX41: a bispecific immune receptor for DNA 
and cyclic dinucleotide. Sci. Rep. 6. 
 
Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P., Yoon, 
C.J., Ellis, P., Wedge, D.C., and Pellagatti, A. (2013). Clinical and biological implications of 
driver mutations in myelodysplastic syndromes. Blood 122, 3616-3627. 
 
Parsyan, A., Svitkin, Y., Shahbazian, D., Gkogkas, C., Lasko, P., Merrick, W.C., and Sonenberg, 






Parvatiyar, K., Zhang, Z., Teles, R.M., Ouyang, S., Jiang, Y., Iyer, S.S., Zaver, S.A., Schenk, 
M., Zeng, S., and Zhong, W. (2012). The helicase DDX41 recognizes the bacterial secondary 
messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. 
Nat. Immunol. 13, 1155-1161. 
 
Patel, S.S., and Picha, K.M. (2000). Structure and function of hexameric helicases. Annu. Rev. 
Biochem. 69, 651-697. 
 
Pause, A., Methot, N., Svitkin, Y., Merrick, W., and Sonenberg, N. (1994). Dominant negative 
mutants of mammalian translation initiation factor eIF‐4A define a critical role for eIF‐4F in cap‐
dependent and cap‐independent initiation of translation. EMBO J. 13, 1205-1215. 
 
Pause, A., and Sonenberg, N. (1992). Mutational analysis of a DEAD box RNA helicase: the 
mammalian translation initiation factor eIF‐4A. EMBO J. 11, 2643-2654. 
 
Pérez-Calero, C., Bayona-Feliu, A., Xue, X., Barroso, S.I., Muñoz, S., González-Basallote, 
V.M., Sung, P., and Aguilera, A. (2020). UAP56/DDX39B is a major cotranscriptional RNA–
DNA helicase that unwinds harmful R loops genome-wide. Genes Dev. 34, 898-912. 
 
Peters, D., Radine, C., Reese, A., Budach, W., Sohn, D., and Jänicke, R.U. (2017). The DEAD-
box RNA helicase DDX41 is a novel repressor of p21WAF1/CIP1 mRNA translation. J. Biol. 
Chem. 292, 8331-8341. 
 
Polprasert, C., Schulze, I., Sekeres, M.A., Makishima, H., Przychodzen, B., Hosono, N., Singh, 
J., Padgett, R.A., Gu, X., and Phillips, J.G. (2015). Inherited and somatic defects in DDX41 in 
myeloid neoplasms. Cancer Cell 27, 658-670. 
 
Popp, H.D., Naumann, N., Brendel, S., Henzler, T., Weiss, C., Hofmann, W.-K., and Fabarius, 
A. (2017). Increase of DNA damage and alteration of the DNA damage response in 
myelodysplastic syndromes and acute myeloid leukemias. Leukemia Res. 57, 112-118. 
 
Py, B., Higgins, C.F., Krisch, H.M., and Carpousis, A.J. (1996). A DEAD-box RNA helicase in 
the Escherichia coli RNA degradosome. Nature 381, 169-172. 
 
Qin, K., Jian, D., Xue, Y., Cheng, Y., Zhang, P., Wei, Y., Zhang, J., Xiong, H., Zhang, Y., and 
Yuan, X. (2021). DDX41 regulates the expression and alternative splicing of genes involved in 
tumorigenesis and immune response. Oncol. Rep. 45, 1213-1225. 
 
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013). Genome 
engineering using the CRISPR-Cas9 system. Nature protocols 8(11), 2281-2308. 
 
Ranoa, D.R.E., Parekh, A.D., Pitroda, S.P., Huang, X., Darga, T., Wong, A.C., Huang, L., 
Andrade, J., Staley, J.P., and Satoh, T. (2016). Cancer therapies activate RIG-I-like receptor 
pathway through endogenous non-coding RNAs. Oncotarget 7, 26496. 
 




biomarker of DNA damage induced by ionizing radiation in human peripheral blood 
lymphocytes and artificial skin. Adv. Space Res. 43, 1171-1178. 
 
Ria, R., Moschetta, M., Reale, A., Mangialardi, G., Castrovilli, A., Vacca, A., and Dammacco, 
F. (2009). Managing myelodysplastic symptoms in elderly patients. Clin. Interv. Aging 4, 413. 
 
Ryan, E.L., Hollingworth, R., and Grand, R.J. (2016). Activation of the DNA damage response 
by RNA viruses. Biomolecules 6, 2. 
 
Rothkamm, K., Barnard, S., Moquet, J., Ellender, M., Rana, Z., and Burdak‐Rothkamm, S. 
(2015). DNA damage foci: Meaning and significance. Environ. Mol. Mutagen. 56(6), 491-504. 
 
Sanchez, A., de Vivo, A., Tonzi, P., Kim, J., Huang, T.T., and Kee, Y. (2020). Transcription-
replication conflicts as a source of common fragile site instability caused by BMI1-RNF2 
deficiency. PLoS Genet. 16, e1008524. 
 
Sanjana, N. E., Shalem, O., & Zhang, F. (2014). Improved vectors and genome-wide libraries 
for CRISPR screening. Nature methods 11(8), 783-784. 
 
Santos-Pereira, J.M., and Aguilera, A. (2015). R loops: new modulators of genome dynamics 
and function. Nat. Rev. Genet. 16, 583-597. 
 
Satoh, Y., Matsumura, I., Tanaka, H., Harada, H., Harada, Y., Matsui, K., Shibata, M., Mizuki, 
M., and Kanakura, Y. (2012). C-terminal mutation of RUNX1 attenuates the DNA-damage 
repair response in hematopoietic stem cells. Leukemia 26, 303-311. 
 
Saygin, C., and Godley, L.A. (2021). Genetics of Myelodysplastic Syndromes. Cancers 13, 3380. 
 
Schwab, R.A., Nieminuszczy, J., Shah, F., Langton, J., Martinez, D.L., Liang, C.-C., Cohn, 
M.A., Gibbons, R.J., Deans, A.J., and Niedzwiedz, W. (2015). The Fanconi anemia pathway 
maintains genome stability by coordinating replication and transcription. Mol. Cell 60, 351-361. 
 
Shah, N., Inoue, A., Woo, L.S., Beishline, K., Lahti, J.M., and Noguchi, E. (2013). Roles of 
ChlR1 DNA helicase in replication recovery from DNA damage. Exp. Cell Res. 319, 2244-2253. 
 
Singleton, M.R., Dillingham, M.S., and Wigley, D.B. (2007). Structure and mechanism of 
helicases and nucleic acid translocases. Annu. Rev. Biochem. 76, 23-50. 
 
Skourti-Stathaki, K., Proudfoot, N.J., and Gromak, N. (2011). Human senataxin resolves 
RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent 
termination. Mol. Cell 42, 794-805. 
 
Smolka, J.A., Sanz, L.A., Hartono, S.R., and Chédin, F. (2021). Recognition of RNA by the S9. 






Sollier, J., and Cimprich, K.A. (2015). Breaking bad: R-loops and genome integrity. Trends Cell 
Biol. 25, 514-522. 
 
Sollier, J., Stork, C.T., García-Rubio, M.L., Paulsen, R.D., Aguilera, A., and Cimprich, K.A. 
(2014). Transcription-coupled nucleotide excision repair factors promote R-loop-induced 
genome instability. Mol. Cell 56, 777-785. 
 
Song, C., Hotz-Wagenblatt, A., Voit, R., and Grummt, I. (2017). SIRT7 and the DEAD-box 
helicase DDX21 cooperate to resolve genomic R loops and safeguard genome stability. Genes 
Dev, 10. 
 
Sridhara, S.C., Carvalho, S., Grosso, A.R., Gallego-Paez, L.M., Carmo-Fonseca, M., and de 
Almeida, S.F. (2017). Transcription dynamics prevent RNA-mediated genomic instability 
through SRPK2-dependent DDX23 phosphorylation. Cell Rep. 18, 334-343. 
 
Sun, M., Zhou, T., Jonasch, E., and Jope, R.S. (2013). DDX3 regulates DNA damage-induced 
apoptosis and p53 stabilization. Biochim. Biophys. Acta Mol. Cell Res. 1833, 1489-1497. 
 
Szappanos, D., Tschismarov, R., Perlot, T., Westermayer, S., Fischer, K., Platanitis, E., 
Kallinger, F., Novatchkova, M., Lassnig, C., and Müller, M. (2018). The RNA helicase DDX3X 
is an essential mediator of innate antimicrobial immunity. PLoS Pathog. 14, e1007397. 
 
Takaoka, K., Kawazu, M., Koya, J., Yoshimi, A., Masamoto, Y., Maki, H., Toya, T., Kobayashi, 
T., Nannya, Y., and Arai, S. (2019). A germline HLTF mutation in familial MDS induces DNA 
damage accumulation through impaired PCNA polyubiquitination. Leukemia 33, 1773-1782. 
 
Tanaka, Y., and Chen, Z.J. (2012). STING specifies IRF3 phosphorylation by TBK1 in the 
cytosolic DNA signaling pathway.  Sci. Signal. 5, ra20-ra20. 
 
Tawana, K., Drazer, M.W., and Churpek, J.E. (2018). Universal genetic testing for inherited 
susceptibility in children and adults with myelodysplastic syndrome and acute myeloid 
leukemia: are I there yet? Leukemia 32, 1482-1492. 
 
Tawana, K., and Fitzgibbon, J. (2016). Inherited DDX41 mutations: 11 genes and counting. 
Blood 127, 960-961. 
 
Tubbs, A., and Nussenzweig, A. (2017). Endogenous DNA damage as a source of genomic 
instability in cancer. Cell 168, 644-656. 
 
Turnell, A.S., and Grand, R.J. (2012). DNA viruses and the cellular DNA-damage response. J. 
Gen. Virol. 93, 2076-2097. 
 
Quesada, A. E., Routbort, M. J., DiNardo, C. D., Bueso‐Ramos, C. E., Kanagal‐Shamanna, R., 
Khoury, J. D., ... & Patel, K. P. (2019). DDX41 mutations in myeloid neoplasms are associated 





Valentini, M., and Linder, P. (2021). Happy Birthday: 30 Years of RNA Helicases. Methods 
Mol. Biol. 2209, 17-34. 
Venema, J., and Tollervey, D. (1999). Ribosome synthesis in Saccharomyces cerevisiae. Annu. 
Rev. Genet. 33, 261-311. 
 
Weinreb, J.T., Ghazale, N., Pradhan, K., Gupta, V., Potts, K.S., Tricomi, B., Daniels, N.J., 
Padgett, R.A., De Oliveira, S., and Verma, A. (2021). Excessive R-loops trigger an inflammatory 
cascade leading to increased HSPC production. Dev. Cell 56, 627-640. e625. 
 
Weinreb, J.T., Gupta, V., Sharvit, E., Weil, R., and Bowman, T.V. (2021). Ddx41 inhibition of 
DNA damage signaling permits erythroid progenitor expansion in zebrafish. Haematologica 
PMID: 33763998. 
 
Yasuhara, T., Kato, R., Hagiwara, Y., Shiotani, B., Yamauchi, M., Nakada, S., Shibata, A., and 
Miyagawa, K. (2018). Human Rad52 promotes XPG-mediated R-loop processing to initiate 
transcription-associated homologous recombination repair. Cell 175, 558-570. e511. 
 
Yu, Z., Mersaoui, S.Y., Guitton-Sert, L., Coulombe, Y., Song, J., Masson, J.-Y., and Richard, S. 
(2020). DDX5 resolves R-loops at DNA double-strand breaks to promote DNA repair and avoid 
chromosomal deletions. NAR Cancer 2, zcaa028. 
 
Zhang, Z., Kim, T., Bao, M., Facchinetti, V., Jung, S.Y., Ghaffari, A.A., Qin, J., Cheng, G., and 
Liu, Y.-J. (2011a). DDX1, DDX21, and DHX36 helicases form a complex with the adaptor 
molecule TRIF to sense dsRNA in dendritic cells. Immunity 34, 866-878. 
 
Zhang, Z., Yuan, B., Bao, M., Lu, N., Kim, T., and Liu, Y.J. (2011c). The helicase DDX41 
senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12, 
959-965. 
 
Zhou, B.-B.S., and Elledge, S.J. (2000). The DNA damage response: putting checkpoints in 



















Permission to use figures 
 






















































































For Figure 9 
 
 
 
